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Introduction 7
A INTRODUCTION
The immune system employs complex strategies in the fight against
invading pathogens. While the innate immune response is an evolutionary ancient
arm of the immune system, vertebrates have also acquired the ability to respond to
pathogens in an adaptive fashion. Adaptive immune responses are provided by T
and B cells. The central molecules in B cell-mediated immunity are the
immunoglobulin (Ig) chains. They form the antigen-recognizing unit of the B cell
receptor (BCR) and contribute effector function as secreted antibodies. The
generation of a broad repertoire of BCR specificities is essential for the effective
humoral immune response. In both human and mouse, this is achieved by two
mechanisms: V(D)J recombination and somatic hypermutation (SHM). The
hallmark of B cell development is the rearrangement of functional Ig genes from a
pool of germline variable (V), diversity (D), and joining (J) gene segments. In T
cell-dependent immune responses, B cells further diversify their BCR repertoire
through the introduction of somatic mutations into the variable region of the Ig
genes, a process called somatic hypermutation (SHM)
A1 V(D)J Recombination
The BCR consists of pairs of identical covalently-linked immunoglobulin
heavy (IgH) and light (IgL) chains that form a complex with the signaling
component of the BCR, the Ig-a/b  heterodimer. Both heavy and light chains
comprise a variable (V) region that confers antigen specificity and a constant
region that mediates effector function in the case of the IgH chain.
The IgH chain is encoded by one gene locus, while there are two loci,
kappa and lambda, that encode the IgL (Honjo and Alt, 1995). Through the
process of V(D)J recombination, the V region of IgH chains is assembled by
joining a variable (VH), diversity (DH), and joining (JH) gene segment (for the
organization of the IgH locus, see Figure 1). The V region of IgL chains is
rearranged similarly. However, IgL loci lack D elements and recombination occurs
only between V and J gene segments (Bassing et al., 2002; Schlissel, 2003).
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Figure 1. Organization and V(D)J recombination of the murine IgH locus.
Variable (VH), diversity (DH) and joining (JH) gene segments are located in the 5’
part of the locus. The exons of the constant region comprise the 3’ part of the
locus. B cells undergo first DH to JH rearrangements (1), followed by VH to DHJH
rearrangements (2). DH to JH rearrangements occur on both alleles, whereas a
productive VH to DHJH rearrangement prevents further rearrangements on the
other allele (allelic exclusion). The reaction is initiated by the enzymes lymphoid-
specific genes RAG-1 and RAG-2 that cleave the DNA within recognition signal
sequences (RSS). Subsequently, ubiquitously expressed non-homologous end-
joining (NHEJ) enzymes resolve the DNA lesions and juxtapose the gene
segments. Rectangles represent gene segments and triangles represent RSSs.
The intronic enhancer (Em) is shown as a circle and switch (S) regions in front of
the constant regions are depicted as ovals. N indicates the number of particular
gene segments in the locus.
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V(D)J recombination is initiated by the lymphoid-specific enzymes recombination-
activating genes 1 and 2 (RAG-1 and RAG-2) (Oettinger et al., 1990; Schatz et al.,
1989). The RAG proteins recognize recognition signal sequences (RSS) flanking
the V, D, and J elements, where they introduce double-strand breaks into the DNA
(McBlane et al., 1995; Oettinger et al., 1990; Schatz et al., 1989; van Gent et al.,
1995). Resolution of the double strand breaks is then mediated by ubiquitously
expressed non-homologous end joining (NHEJ) enzymes and leads to the
juxtaposition of a V, D, and J gene segments (Barnes et al., 1998; Blunt et al.,
1995; Critchlow et al., 1997; Frank et al., 1998; Grawunder et al., 1997;
Kirchgessner et al., 1995; Nussenzweig et al., 1996; Zhu et al., 1996). V(D)J
recombination is not precise. In adult mice, the DNA joints are trimmed and the
lymphoid-specific terminal desoxynucleotidyl transferase (TdT) (Alt and Baltimore,
1982; Gilfillan et al., 1993; Komori et al., 1993) inserts randomly non-templated
nucleotides (N-nucleotides). Recently, the related DNA polymerase m (Bertocci et
al., 2003) has also been implicated in the processing of the DNA joints. Thus,
these processes contribute additional antibody diversification.
V(D)J recombination is an ordered process, whose regulation is thought to
involve chromatin modifications in the Ig loci, which render the loci accessible for
the RAG proteins (Mostoslavsky et al., 2003; Schlissel, 2003). In the majority of B
cells, rearrangement of the IgH locus precedes the rearrangement of the IgL loci.
Expression of a productive (functional) IgH chain terminates further recombination
of the IgH loci, a process termed “allelic exclusion”, which induces the onset of IgL
rearrangements. Allelic exclusion and light chain isotype exclusion of the IgH and
IgL loci confines B cells to the expression of a single BCR specificity.
A2 B Cell Development
 Murine B cell development occurs in the fetal liver during embryogenesis
and continues in the bone marrow after birth (Owen et al., 1977). Based on the
expression of surface antigens, B cell development can be separated into several
distinct stages (Figure 2) (Hardy et al., 1991; Rolink et al., 1994; Rolink and
Melchers, 1996) that correlate with the progression of V(D)J recombination
(Rajewsky, 1996).
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Figure 2. B cell development. Pro-B cells are the earliest B cell progenitors. In most
cases, V(D)J recombination commences at the IgH loci. DH and JH gene segments are
rearranged first, followed by VH to DHJH rearrangements. Cells carrying a productive
(functional) V(D)J rearrangement progress to become pre-B cells. The IgH chain pairs
with the surrogate light chain to form the pre-B cell receptor (pre-BCR). Signaling through
the pre-BCR terminates further rearrangements at the IgH loci and allows pre-B cells to
continue with IgL chain rearrangements. Productive VL to JL rearrangements result in the
expression of a functional BCR. Signaling through the BCR terminates V(D)J
recombination and allows pre-B cells to differentiate into immature B cells, which  mature
in the secondary lymphoid organs. Figure is adapted from Rajewsky, 1996 (Rajewsky,
1996).
B cell progenitors develop into pro-B cells (B220+CD43+IgM-IgD-), with DH to JH
rearrangements occurring first, followed by VH to DHJH rearrangements (Alt et al.,
1984). Cells carrying a productive IgH rearrangement become pre-B cells
(B220+CD43-IgM-IgD-). In pre-B cells, IgH chains pair with a surrogate light chain,
consisting of the VpreB and l5 molecules, to form the pre-BCR (Karasuyama et
al., 1990; Tsubata and Reth, 1990). Signaling through the pre-BCR is thought to
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terminate further IgH rearrangements and enables the cell to progress to IgL chain
rearrangement (Kitamura et al., 1992; Löffert et al., 1996). Successful completion
of the IgL rearrangement allows the expression of a functional BCR, which
terminates further IgL chain rearrangements (Grawunder et al., 1995; Li et al.,
1993). B cells that recognize auto-antigens through their BCR either alter their
BCR specificity by receptor editing of the IgL or are negatively selected (Gay et al.,
1993; Nemazee and Burki, 1989; Retter and Nemazee, 1998; Tiegs et al., 1993).
Only those cells with “innocent” (non-autoreactive) receptors differentiate into
immature B cells (B220+CD43-IgM+IgD-). Further maturation occurs then in the
secondary lymphoid organs (Allman et al., 1993).
Mature B cells fall into three subsets that can be distinguished by the
differential expression of surface antigen markers and their distinct homing and
functional properties. B-1 cells (IgMbrightIgDlowB220lowCD23lowCD43+) are self-
renewing cells derived from fetal precursors. They are found mainly in the
peritoneal and pleural cavities and provide most of the “natural” IgM antibodies,
thus contributing to innate immune responses (Hardy and Hayakawa, 2001;
Hayakawa et al., 1983; Herzenberg et al., 1986; Kocks and Rajewsky, 1989; Su
a n d  Tarakhovsky,  2000) .  Marg ina l  zone (MZ) B ce l ls
(IgMhighIgDlowCD21highCD23low) are self-renewing cells that appear in the spleen
shortly after birth. They are non-circulating and are recruited into humoral
responses raised against blood-borne antigens (Martin and Kearney, 2002).  Most
B cells in adult mice differentiate into follicular B cell (also called B-2 cells).
Follicular B cells are IgMhighIgDlowCD21lowCD23high. They are re-circulating cells
that home to B cell follicles in the secondary lymphoid organs and are the major B
cell subset recruited into antibody responses against T cell-dependent antigens
(Rajewsky, 1996). The molecular mechanism that governs the differentiation into
the distinct subsets of mature B cells is not fully understood. However, current
understanding suggests that the strength of the BCR-mediated signal is the critical
determinant for the differentiation into the mature B cell subsets (Cariappa and
Pillai, 2002).
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A3 The Germinal Center Reaction
In T cell-dependent (TD) antibody responses, follicular B cells are activated
in the T cell zone of the secondary lymphoid organs by BCR-mediated antigen
recognition and T cell help. Upon activation, most B cells differentiate into short-
lived antibody-secreting plasma cells (Ho et al., 1986). The latter cells retain their
unmutated Ig genes and provide an initial wave of low-affinity antibodies. A fraction
of the activated B cells migrate to the B cell follicles, where they undergo a phase
of rapid proliferation and form distinct histological structures in secondary lymphoid
organs, the germinal centers (GCs) (MacLennan, 1994; Tarlinton, 1998).
Germinal centers are the sites of secondary antibody diversification.
Somatic hypermutation (SHM) introduces mutations into the pre-rearranged Ig
genes, thus generating novel mutated BCRs. A second process, called class
switch recombination (CSR), modifies the IgH constant region by replacing the
constant region of IgM with that of another isotype to modify effector function.
Murine GC B cells can be distinguished from follicular B cells by their ability to bind
to the plant lectin peanut agglutinin (PNA), the increased surface expression of
GL-7 and the Fas receptor, and the reduced surface levels of IgD. Germinal
centers at the peak of the GC reaction have a polarized appearance (Figure 3).
The dark zone adjacent to the T cell zone contains proliferating B cells (called
centroblasts), whereas the light zone comprises non-dividing B cells (called
centrocytes) interacting with a network of follicular dendritic cells (FDCs)
(Schriever and Nadler, 1992). Centroblasts divide every 7 hours, and undergo
SHM (MacLennan, 1994). After the proliferative burst, centroblasts exit the cell
cycle and become centrocytes. Centrocytes compete with each other for access to
antigens held in the form of immune complexes on the FDCs (Mandel et al., 1980).
During affinity maturation, centrocytes with high-affinity BCRs are positively
selected and differentiate into long-lived plasma cells or memory B cells, while
those cells with a non-functional or low-affinity BCR fail to get selected and die by
apoptosis.
Terminal differentiation of plasma cells alters the gene expression required
for BCR signaling and GC function (Shaffer et al., 2002). Guided by chemokines,
long-lived plasma cells migrate preferentially to the bone marrow, where they
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Figure 3. Structure of germinal centers in humans (A) and mice (B). GC B cells can
be divided into centroblasts and centrocytes. Centroblast proliferate in the dark zone (DZ)
adjacent to the T cell zone and undergo SHM. Centroblasts give rise to centrocytes. The
latter cells interact in the light zone (LZ) with follicular dendritic cells (FDCs). A. Germinal
center in a human tonsil. Centroblasts are stained for the proliferation marker Ki-67 in
green, T cells are stained in blue, and FDCs are stained in red. B. Germinal center in the
spleen of an immunized mouse.  PNA-binding GC B cells are stained in red, FDCs in
purple, and CD19-positive B cells in green. FM indicates the follicular mantle zone, which
consists of resting B cells. Figure 3A is adapted from the homepage of the MacLennan
laboratory (http://www.bham.ac.uk/mrcbcir/research.htm#reg%20imm%20responses).
secrete large amounts of antigen-specific antibodies (Benner et al., 1981; Cyster,
2003; Manz et al., 1997; McMillan et al., 1972). Memory B cells persist in
secondary lymphoid organs after the termination of the TD immune response in
the absence of further contact with antigen (Maruyama et al., 2000) and represent
the first B cell subset recruited into secondary antibody responses.
A4 Class Switch Recombination (CSR)
The nature of the IgH constant region defines the antibody isotype. The
activation with cognate antigen, the presence of cytokines, and to some degree T-
FM
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cell help, induce IgM and IgD-expressing follicular B cells to undergo CSR in order
to express other isotypes (Manis et al., 2002; Stavnezer, 1996).
The IgH constant region gene segments (CH) cluster at the 3’ end of the
locus, starting in the mouse with the VH-proximal Cm encoding IgM followed by Cd,
Cg3. Cg1, Cg2b, Cg2a, Ce and Ca  (Figure 4). Upon CSR, B cells express a
different isotype by replacing Cm with a downstream CH and concurrent excision of
the intervening DNA (Iwasato et al., 1990; Matsuoka et al., 1990). Each CH gene
segment represents a discrete transcriptional unit that comprises its own promoter,
a GC-rich repetitive sequence (switch (S) region) and the exons of the constant
region. CSR occurs between the S regions located up-stream of each constant
region and is dependent on CH
 promoter-driven germline transcription through the
S regions (Bottaro et al., 1994; Harriman et al., 1996; Jung et al., 1993; Zhang et
al., 1993). Transcription leads to the formation of stable RNA-DNA structures
(termed R-loops) that displace the non-coding DNA strand (Reaban and Griffin,
1990; Reaban et al., 1994; Yu et al., 2003; Yu and Lieber, 2003). The R-loops are
thought to assist in the targeting of the recombination machinery. The DNA breaks
occur within the S regions and the resulting DNA ends are joined by the NHEJ
pathway (Casellas et al., 1998; Manis et al., 1998; Rolink et al., 1996). As a result
of CSR, the intervening DNA fragment is excised as a circle and the 3’ and 5’ ends
of the IgH locus are juxtaposed.
A5 Somatic Hypermutation (SHM)
During SHM, the pre-rearranged Ig genes acquire point mutations at a very
high rate (around 10-3/bp/generation) (Kocks and Rajewsky, 1988; McKean et al.,
1984). Transcription of the Ig genes is essential for SHM and the transcription rate
correlates with the mutation frequency (Fukita et al., 1998; Storb et al., 1998b).
Mutations accumulate in a 2 kb window downstream of the promoter (Neuberger et
al., 1998; Rada and Milstein, 2001; Storb et al., 1998a), thus covering the V gene
region but not the constant regions. The presence of Ig enhancers is required for
SHM and the targeting of the SHM machinery to the Ig genes is thought to involve
changes in the chromatin structure of the Ig V region (Jolly and Neuberger, 2001;
Woo et al., 2003). The mutations do not occur entirely randomly (Jolly et al., 1996).
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Transitions (purine to purine or pyrimidine to pyrimidine mutations) dominate over
transversions (purine to pyrimidine or pyrimidine to purine mutations) and guanine
mutations often accumulate in the context of the RGYW motif (R = A or G, G, Y =
C or T, W = A or T) (Betz et al., 1993; Rogozin and Kolchanov, 1992). These sites
are therefore also called hot spots of mutations. Within the V genes, adenine
mutations are favored over thymidine mutations, indicating a strand bias for A-T
but not G-C mutations. Finally, the occurrence of small deletions and duplications
within the Ig genes has led to the suggestion that SHM involves the generation of
DNA strand breaks (Goossens et al., 1998; Sale and Neuberger, 1998).
 While many cis-acting elements required for SHM have been identified
(Neuberger et al., 1998; Storb et al., 1998a), less is known about the molecular
components necessary for this process. Many models of the mechanism for SHM
postulated the introduction of single-strand or double-strand breaks into the DNA
with subsequent error-prone short-patch synthesis by one or more DNA
polymerases (Bertocci et al., 1998; Brenner and Milstein, 1966; Diaz et al., 1999).
The presence of DNA double strand breaks within the RGYW motif in rearranged
Ig genes of cells undergoing SHM has indeed been demonstrated (Bross et al.,
2000; Papavasiliou and Schatz, 2000). They may occur preferentially during S/G2
phase, suggesting a resolution of the lesion via template-directed homologous
recombination. However, the molecular origin of the double-strand breaks and
their significance for the SHM process remain unclear (Bross et al., 2002;
Papavasiliou and Schatz, 2002).
A6 The Deamination Model
Although SHM and CSR differ in many aspects, they both depend on the
function of the GC B cell-specific activation-induced cytidine deaminase (AID)
(Muramatsu et al., 2000; Revy et al., 2000). This indicates shared features
between the two mechanisms, which is further illustrated by the observation of
somatic mutations within the S regions (Nagaoka et al., 2002; Reina-San-Martin et
al., 2003). Humans and mice that lack AID are unable to undergo CSR or SHM.
Since AID appears to be the only B cell-specific factor required for both CSR and
SHM (Okazaki et al., 2002; Yoshikawa et al., 2002), a common initiation event
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Figure 4. Somatic hypermutation (SHM) and class switch recombination (CSR). SHM
(1) introduces mainly point mutations into the rearranged V region of the Ig genes to
generate novel mutant BCRs for the immunizing antigen. CSR (2) alters the IgH constant
region to modulate the type of antibody response. CSR occurs between two switch (S)
regions, thus replacing the Cm region with the constant region of another isotype.
Mutations are depicted as red ‘X’, exons are represented as rectangles, and S regions are
shown as ovals.
likely exists for both reactions, which are then resolved in different ways.
AID shares homologies with the RNA-editing enzyme Apobec-1, a cytidine
deaminase that converts a cytidine residue into a uracil residue in the mRNA of
apolipoprotein B.  Consequently, AID could act on an unknown mRNA to modify
one or several factors required for CSR or SHM. Further supporting this
assumption, CSR does indeed require the de novo protein synthesis. (Doi et al.,
2003). Most evidence suggests, however, that AID acts directly on DNA. Over-
expression of AID in E.coli results in DNA deamination and increased cytidine
mutatagenesis (Petersen-Mahrt et al., 2002). Furthermore, AID has a low affinity
for RNA but a high affinity for single-stranded DNA and during transcription also for
double-stranded DNA (Bransteitter et al., 2003; Chaudhuri et al., 2003; Dickerson
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et al., 2003; Ramiro et al., 2003).
Accordingly, the DNA deamination model of SHM (Neuberger et al., 2003;
Petersen-Mahrt et al., 2002) proposes that the localized deamination of cytidine
residues by AID at the Ig V loci leads to U-G mismatches, which can be resolved
in three ways (Figure 5). First, replication across the uracil templates results in G-
C to A-T transitions. Second, excision of the uracil residues by uracil-DNA-
glycosylases creates an abasic site, and subsequent error-prone replication of the
damaged DNA strand introduces a spectrum of mutations. Alternatively, the abasic
site is nicked and further processed by a combination of nucleases and error-
prone DNA polymerases. Third, the mismatch-repair enzymes MSH2 and MSH6
recognize the U-G mismatch and the lesion is resolved by nucleases and error-
prone short-patch DNA replication. Similar to SHM, AID may initiate the events
leading to CSR after association with the non-transcribed DNA strand and
subsequent deamination of cytidines. The resulting uracil lesions are then further
processed, leading ultimately to the generation of DNA breaks. It is important to
note, however, that the C-terminus of AID is required for CSR, but not for SHM
(Barreto et al., 2003), suggesting a role for AID in the recruitment of NHEJ or other
proteins that are dispensable for SHM. Several aspects of the DNA deamination
model are supported by experimental evidence. E. coli over-expressing AID
display an increased number of transitions when the uracil glycosylase UNG is
inhibited (Di Noia and Neuberger, 2002) and UNG-deficient mice display a
significant increase in the number of transition mutations in GC B cells (Rada et
al., 2002). Such mice are also impaired in CSR, demonstrating the importance of
uracil deglycosylation in the CSR mechanism (Rada et al., 2002). Moreover, AID
targets hotspots on single stranded DNA in vitro (Pham et al., 2003). Finally, mice
that lack enzymes involved in MSH2-mediated DNA repair display a shift towards
G-C mutations in their mutational pattern (Ehrenstein et al., 2001; Jacobs et al.,
1998; Phung et al., 1998; Rada et al., 1998).
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Figure 5. The deamination model. AID deaminates cytidines within the Ig genes. The
resulting U-G mismatches are then resolved in three ways. 1) Replication across uracil
templates results in G-C to A-T transitions. 2) Excision of the uracil residues by UNG
creates an abasic site. Subsequent error-prone replication across the abasic site
introduces mutations. 3) MSH2 and MSH6 recognize the U-G mismatch and the lesion is
resolved by nucleases and error-prone short-patch DNA synthesis. Cytidine deamination,
followed by the removal of the uracil residues and introduction of DNA-strand breaks may
also initiate CSR. Adapted from Petersen-Mahrt et al., 2002.
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A7 The Role of error-prone DNA Polymerases in SHM
While cytidine deamination by AID may explain the presence of G-C to A-T
transitions, SHM encompasses the whole spectrum of both transitions and
transversions, suggesting that the mutations are at least in part caused by error-
prone DNA polymerases. Besides the proof-reading error-free DNA polymerases
required for genome replication, humans and mice express many non-replicative
error-prone DNA polymerases that are able to bypass DNA adducts and extend
from mismatched termini (Friedberg et al., 2002; Goodman, 2002; Jansen and de
Wind, 2003). The specialized function of trans-lesion synthesis marked error-prone
DNA polymerases as potential contributors to SHM (Reynaud et al., 2003).
The error spectrum of Polh in vitro correlates with hotspot mutations at the
RGYW motif in SHM (Pavlov et al., 2002; Rogozin et al., 2001). Polh is defective in
patients with the variant form of xeroderma pigmentosum (XP-V), a disease that
predisposes to skin cancer due to a increased sensitivity to UV radiation (Masutani
et al., 1999). SHM occurs at normal frequencies in XP-V patients but displays a
bias towards G-C mutations and a decrease in mutations at A-T base pairs,
demonstrating a contribution of Polh to SHM (Zeng et al., 2001).
Polymerase i is characterized by its very low fidelity and mRNA expression
of Poli has been demonstrated in a cell line undergoing SHM (Johnson et al.,
2000b; Poltoratsky et al., 2001; Tissier et al., 2000). The inactivation of Poli in the
hypermutating cell line resulted in a substantial decrease in the mutation frequency
(Faili, 2002). Surprisingly, Poli-deficient mice mutate their Ig genes in GC B cells
efficiently and without changes in their mutational pattern (McDonald et al., 2003).
Polymerase z is responsible for most of the UV-radiation-induced and
spontaneous mutagenesis. It is very efficient in extending DNA from mismatched
termini (Lawrence and Hinkle, 1996). Polymerase z may introduce mutations in
vivo by extending from mismatches formed by Poli, a mechanism that has been
shown to occur in vitro using recombinant yeast rev3 (the catalytic subunit of Polz)
and recombinant human Poli (Johnson et al., 2000b). Expression of Polz mRNA is
upregulated in GC B cells. Lack of Polz causes embryonic lethality in mice
(Bemark et al., 2000; Esposito et al., 2000a; Wittschieben et al., 2000). However,
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RNA antisense inhibition of Rev3 (the catalytic subunit of mammalian Polz) in a
hypermutating cell line reduced the frequency of SHM (Zan et al., 2001) and
transgenic mice expressing Rev3l antisense RNA exhibited a decreased level of Ig
mutations (Diaz et al., 2001). In both experiments, the pattern of the mutations was
still normal.
Polymerase m is the only error-prone DNA polymerase that displays a
lymphoid-specific expression pattern (Dominguez et al., 2000; Reynaud et al.,
2001). It shares homologies with TdT, acts in a template-dependent but sequence-
independent manner (Dominguez et al., 2000; Reynaud et al., 2001), and is
involved in the processing of the junctions of IgL genes (Bertocci et al., 2003).
Because of its expression in peripheral B cells, it was also considered to play a
role in SHM. However, Polm-deficient mice show normal SHM (Bertocci et al.,
2002). Likewise, the analysis of mouse strains deficient of Polb (Esposito et al.,
2000b), Pold (Longacre et al., 2003), or Poll (Bertocci et al., 2002) also failed to
detect a contribution of these DNA polymerases to SHM. However, the example of
Poli-deficient mice (required for SHM in a hypermutating human B cell line but
dispensable in mice) raises the possibility of overlapping functions of error-prone
DNA polymerases in SHM.
A8 DNA Polymerase Kappa
Polymerase k (DinB1) is expressed in high levels in mouse testis, but
also at lower levels in a wide variety of other tissues, including the spleen (Gerlach
et al., 1999; Johnson et al., 2000a). Like Polh and Poli, it is a member of the Y
family of DNA polymerases (Ohmori et al., 2001) and shares extensive amino-acid
homology with the SOS-induced error-prone DNA polymerase PolIV, the product
of the E. coli dinB gene (Gerlach et al., 1999). Polymerase k lacks detectable 3’-5’
proofreading exonuclease activity and replicates undamaged DNA in vitro at a
single-base substitution error rate of ≈ 6x10-3 (Gerlach et al., 2001; Ohashi et al.,
2000; Zhang et al., 2000b). Polymerase k can act as mismatch extender during
translesion synthesis (Haracska et al., 2002; Washington et al., 2002) and abasic
sites similar to those created by UNG can serve substrates for Polk (Zhang et al.,
2000a). Over-expression of murine Polk in a mouse cell line results in about a 10-
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Figure 6. Phylogenetic tree of Y-family error-prone DNA polymerases. Pol k (DinB1),
Polh (Rad30A) and Poli (Rad30B) are members of the the Y-family of DNA polymerases,
while TdT, Polm, and Poll belong to the X-family of DNA polymerases. Polb and Polz
(Rev3/Rev7) are members of the B-family of DNA polymerases. Adapted from Ohmori
et al., 2001.
fold increase of spontaneous mutagenesis (Ogi et al., 1999). Moreover, a
comparison between the mutational patterns of SHM and Polk in vitro suggested a
possible contribution of Polk to SHM (Rogozin et al., 2001). These features mark
Polk as a potential candidate for a specialized DNA polymerase required for SHM.
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A9 M17
GCs are the origin of several B cell malignancies due to aberrant SHM or
CSR (Klein, 1999; Kuppers et al., 1999; Pasqualucci et al., 2001). Diffuse large B
cell lymphomas (DLBCL) represent a heterogeneous group of GC-derived tumors,
which often harbor mutations characteristic of SHM in proto-oncogenes like BCL6
and M Y C  (Pasqualucci et al., 2001). Human germinal center-associated
lymphoma (HGAL) is a cytosolic protein that is expressed at high levels in GCs
and at moderate levels in the thymus (Lossos et al., 2003; Pan et al., 2003).
Expression of HGAL mRNA is also found in a subset of DLBCL, where it can serve
as a marker for the clinical prognosis of patients with DLBCL (Lossos et al., 2003;
Rosenwald et al., 2002). High expression of the HGAL gene correlates with a
better prognosis and longer survival.
In an attempt to identify genes that govern the GC reaction, the cDNA
encoding the murine counterpart of HGAL, M17, was previously isolated in our
laboratory by cDNA subtraction between GC B cells and LPS-stimulated
splenocytes. M17 is a putative cytosolic 25 kD protein, which is predominantly
expressed in GC B cells (Christoph et al., 1994) Within the GCs, M17 mRNA
expression appears stronger in centroblasts than in centrocytes (Christoph, 1993).
The M17 and HGAL genes share a similar exon-intron structure. At the protein
level, they contain several potential phosphorylation sites that also include a non-
canonical immune tyrosine activation motive (ITAM), indicating a role in cell
signaling (Christoph et al., 1994). The function of M17 is unknown. However, its
site of expression is suggestive of a role of M17 in the GC reaction, where it may
contribute to CSR, SHM or to the proper selection and differentiation of GC B cells
to the memory B cell or plasma cell compartments.
A10 Objectives of This Study
When I started my thesis, a plethora of novel error-prone DNA polymerase
had just been discovered, some of which had been implicated to play a role in
SHM mechanism. Polymerase k showed features in vitro that were compatible with
such a role. Consequently, I sought to study its contribution to the SHM
mechanism in vivo. I first inactivated the Polk gene by conditional gene targeting
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and subsequently probed Polk-deficient mice for SHM. I then extended the initial
study and asked whether Polk acts in concert with other DNA polymerases in
SHM. In addition to its role in SHM, Polk may also affect DNA repair, survival, or
reproduction. I briefly addressed these aspects in the context of this thesis.
In a quest to identify gene that are specifically expressed in GCs, our
laboratory had previously identified the novel M17 gene and also generated a
mouse strain, in which M17 had been inactivated. Because of my interest in
mechanisms regulating the GC reaction, I started to characterize the function of
M17 in vivo and the findings of this investigation are presented here.
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B MATERIAL AND METHODS
B1 Molecular Biology Experiments
All molecular biology techniques were based on standard protocols (Sambrook et
al., 1989). Enzymes were obtained from Roche, GIBCO-BRL, New England Biolabs,
Stratagene, Takara, Invitrogen, Promega, Eppendorf, and USB.
B1.1  Competent Cells and Isolation of Plasmid DNA
Escherichia coli XL-1 Blue cells were made chemically competent according to the
protocol of Inoue et al. (Inoue et al., 1990). Plasmid DNA was isolated from transformed
Escherichia coli XL-1 Blue bacteria by alkaline lysis (Birnboim, 1983). For higher quality
plasmid DNA purification, QIAGEN spin columns (QIAGEN) were used according to
manufacturer’s instructions.
B1.2 Isolation of Genomic DNA from Mammalian Cells
Cells were lysed in lysis buffer (10 mM Tris-HCl, pH 8; 10 mM EDTA; 150 mM
NaCl; 0.2% SDS; 400 mg/ml Proteinase K) over night at 56°C. DNA was precipitated from
the solution by the addition of an equal volume of isopropanol and pelleted by
centrifugation. The pallet was washed in 70% ethanol and resuspended in TE-buffer (10
mM Tris-HCl, pH 8; 1 mM EDTA). For ES cell clones that were grown in 96-well tissue
culture dishes, a modified protocol was used (Pasparakis and Kollias, 1995).
Mouse tissues were incubated in lysis buffer (0.1 M Tris-HCl, pH 8.5; 5 mM EDTA;
0.2% SDS; 0.2 M NaCl; 600 mg/ml Proteinase K) over night at 56°C. The solution was
freed of undissolved debris by centrifugation and the supernatant was mixed with an equal
volume of isopropanol to precipitate the DNA. The DNA was washed in 70% ethanol,
dried, and resuspended in TE buffer.
B1.3 Agarose Gel Electrophoresis and DNA Gel Extraction
Separation of DNA fragments by size was achieved by electrophoresis in agarose gels
(0.7% - 2.5%; TAE buffer (Sambrook et al., 1989); 0.5 mg/ml ethidiumbromide). DNA
fragments were recovered from agarose gel slices with either the QIAEX II or the
QIAquick Gel Extraction Kits (QIAGEN) according to the supplied protocols.
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B1.4 DNA Sequencing
DNA fragments were sequenced using the Taq DyeDeoxyTerminator Cycle
Sequencing Kit (Applied Biosystems) The fluorescently labeled DNA pieces were
separated and analyzed on ABI373A and ABI377 systems (Applied Biosystems) with the
help of S. Wilms. Alternatively, the sequencing was performed by the Harvard Cancer
Center High Throughput Facility, Boston, USA. The Polk locus was sequenced by the
Friedberg laboratory at the Southwestern Medical Center, Dallas, USA.
B1.5 Polymerase Chain Reaction (PCR)
PCR (Mullis and Faloona, 1987; Saiki et al., 1985) was employed for the amplification of
DNA fragments used for cloning, the generation of Southern probes, and the screening of
mice for the presence of targeted alleles. Reactions were performed with either Taq
polymerase (Eppendorf) or the High Fidelity Expand kit (Roche) following manufacturer’s
instructions. The primers are listed in Tables 1a-c.
Table 1a: Primers used for cloning and generation of Southern probes
NAME SEQUENCE (5’-3’) LOCATION
TAnn
[°C]
SABamFor CGGGATCCCGTGGGGGAGGGGCAGCGG Polk 57
SANotBack ATTTGCGGCCGCTTTAACAGTGTGAGTCTTAG Polk 57
LANotFor AACATGCTCGAGTACTCTAGAGTAGTTGCAGAGC Polk 57
LANotBack CCGCTCGAGCGGAGTGTTTTTGCTGTTTGTC Polk 57
ExSalForII ACGCGTGACGTCGACGTTTCGTGTGATAACGC Polk 57
ExSalBack ACGCGTCGACGTGGCACAGCAAGGTCTATGGTG Polk 57
DinProbeA-F2 CAATGGCTACTCTTGCCTTGTG Polk 57
DinProbeA-Re CTTGAAAGATCCACCAATCACCTG Polk 57
M26 CTACTTATTCTGCTTGGATGC M17 58
M57 CCACCAGGCACTGCAAATGGC M17 58
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Table 1b: Primers used for the typing of mice
NAME SEQUENCE (5’-3’) LOCATION TAnn
[°C]
DinB1Seq6 CTGATGTGACCGCTGTTAAATGTT Polk 57
DinB1Seq8 CTGTGGAGATGCCTTAGCGG Polk 57
DinB1Seq10 GATCCTGCAATCAATAGCTCACGG Polk 57
PT26 GTGCTGATCACAGAAATGGAAGGACCTGGA Poll 65
PT29 GGTCAAGGACACTAAGCTACATGGCTGTTC Poll 65
Seq9new CTGGTCTCTGGGAACCAAAGGAC Poll 65
ScNeoR1 GGGGCCACCAAAGAACGGAGC neo 65
MuexIInew ACCAATGGAGAGGTGCTCTCCC Polm 65
T2.14OAs GGCAGGGCAGGGACTTGAGCA Polm 65
mRad30X2F CAGTTTGCAGTCAAGGGCC Poli 57
mRad30X2R TCGACCTGGGCATAAAAGC Poli 57
M17-FLS#87 CTACTTATTCTGCTTGGATGC M17 58
M17-FLA#88 AGGCTAGACAGAGAACATACG M17 58
M17-SAS#74 TGTGGAGAGAAAGGCAAAGTG M17 58
MP 57 CCACCAGGCACTGCAAATGGC M17 58
MP 26 CTACTTATTCTGCTTGGATGC M17 58
5’Del CGCATAACCAGTGAAACAGCAT Del-Cre 58
Mx-CreR GAAAGTCGAGTAGGCGTGTACG Del-Cre 58
Table 1c: Primer combinations and expected sizes of PCR products for the typing of mice
PRIMERS MOUSE STRAIN ALLELE PRODUCT [bp]
DinB1Seq6, DinB1Seq10 Polk WT 685
DinB1Seq6, DinB1Seq10 Polk FL 731
DinB1Seq6, DinB1Seq8 Polk WT 1655
DinB1Seq6, DinB1Seq8 Polk DEL 413
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PT29, Seq9new Poll WT 500
PT26, ScNeoRI Poll DEL 600
MuexIInew, T2.14OAs Polm WT 780
MuexIInew, ScNeoRI Polm DEL 600
mRad30X2F, mRad30X2R * Poli WT 87
mRad30X2F, mRad30X2R * Poli DEL 47, 40
M17-FLS#87, M17-FLA#88 M17 WT 256
M17-FLS#87, M17-FLA#88 M17 FL 300
M17-FLS#87, M17-SAS#74 M17 DEL 500
5’Del, Mx-CreR Deleter-Cre Cre 600
* plus digestion of PCR product with TaqI
B1.6 Southern Blot Analysis
5-15 mg DNA were digested with 50 to 100 U of the appropriate restriction enzyme
over night. Subsequently, the DNA fragments were resolved by agarose gel
electrophoresis and transferred onto HybondTM-N+ (Amersham) by an alkaline capillary
transfer according to the method of Chomczynski and Qasba (Chomczynski and Qasba,
1984). Membranes were baked at 80°C for 2 hours to fix the DNA, equilibrated in 2x SSC
(Sambrook et al., 1989) and then prehybridized in hybridization solution (1M NaCl, 1%
SDS, 10% dextran sulfate, 50 mM Tris-HCl pH 7.5, 500 mg/ml sonicated salmon sperm
DNA) over night at 65 °C.
25 to 60 ng of probe DNA were radioactively labeled with 2.5 mC [a32P]-dATP
(Amersham) using the LaddermanTM Labeling Kit (Takara) Unincorporated radiolabeled
nucleotides were removed with MicroSpinTM S-200HR columns (Pharmacia). The probe
was denatured for 5 min at 95 °C before it was added to the hybridization solution.
Washes were performed twice in 1 x SSC/0.1 % SDS and then followed by washes in
0.5 x SSC/0.1 % SDS and 0.25 x SSC/0.1 % SDS, if necessary. All washes were done at
65 °C under gentle agitation for 15 min to 1 hour. After each wash, the filter was monitored
with a Geiger-counter. The washes were stopped when specific signals of no more than
100 cps were detectable. The membrane was sealed in a plastic bag and exposed to X-
ray film (Kodak XAR-5 or BioMAX MR; Eastman Kodak) at –70 °C.
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B1.7 Construction of the Polk Targeting Vector
A phage library containing 129/Sv mouse genomic DNA (a gift from Pila Estess
and Mark Siegelman, Department of Pathology, UT Southwestern, USA) cloned into the
phage l 2001 vector was screened by plaque hybridization according to published
protocols (Sambrook and Russell, 2001). Two different mouse PolK (DinB1) probes were
used to screen the library: the 550 bp-Xba I/EcoN I fragment from pMDPH5'-0.7
(corresponding to mouse Polk  5' UTR and amino acids 1-138) and the 700 bp-
MDPH1C/4NC PCR product (corresponding to mouse Polk amino acids 110 to 332). DNA
Figure 7. Drawing of the pEasyFLox vector. LoxP sites are represented as black
triangles. neor, neomycin resistance gene; tk, thymine kinase gene; ampr, ampicillin
resistance gene.
from positively hybridizing plaques was isolated, cloned into pBlueScript, and
subsequently sequenced. The sequences were assembled into contigs using the
assembly software DNASTAR (the genomic clone was cloned in collaboration with Valerie
Gerlach and Errol Friedberg, UT Southwestern Medical Center, Dallas, TX, USA).
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A genomic subclone, p129Xh9, spanning exons 4-6 was used for the construction
of the targeting vector. The targeting vector is based on the pEasyFlox(Pac) vector
(Figure 7, M. Alimzhanov, unpublished), which contains a neomycin resistance  gene
under the control of the phosphoglycerol kinase promoter flanked by two loxP sites. An
additional loxP site is placed downstream of the neomycin resistance cassette. An 800 bp
fragment of genomic DNA located downstream of exon 6 was used as short arm of
homology (SA). It was generated by PCR amplification with the Expand High Fidelity Kit
(Roche), using the primers SABamFor1 and SANotBack, which introduced the restriction
sites Not I and BamH I. Similarly, the primers LAXhoFor and LAXhoBack were used to
amplify a 4.3 kb fragment including exon 5 for the long arm of homology (LA). A 1.3 kb
fragment containing exon 6 was inserted into a Sal I site separating the second and third
loxP site of pEasyFlox(Pac). The required Sal I sites in the PCR fragment were introduced
with the primer pair Ex6SalForII and ExSalBack. All PCR products were first cloned into
the T/A cloning vector pGEM-T easy (Promega) (plasmids pGEM-SA, pGEM-LA, and
pGEM-Ex6) and then subcloned into the targeting vector. The exons and exon/intron
boundaries were sequenced to confirm the absence of PCR-introduced errors.
B1.8 Construction of the M17 Targeting Vector
DNA fragments containing parts of the M17 locus were obtained by screening a
phage library containing C57BL/6 mouse genomic DNA. Two EcoR I-fragments were
subcloned into the pBluescript II KS vector (pBS-IIKS). The first vector, designated
pDS#9, contained a fragment of 6.9 kb encoding M17 exons 3, 4 and a part of exon 5 and
the second vector, termed pDS#10, contained a fragment of 7.8 kb encoding M17 exon 5.
A Sca I-EcoR I fragment was cut out of pDS#9 and a EcoR I-EcoR V fragment was cut out
of pDS#10 and both fragments were cloned together into pBS-IIKS using the EcoR V
restriction site. The new plasmid was termed pBS-M17LA1. Next, a EcoR V-fragment
derived from pDS#9 was cloned into the EcoR V restriction site of pBS-IIKS, which
contained a destroyed Xba I restriction site, and the new vector was named pBS-M17-
EcoRV. To clone the frt-flanked SAS-IRIS-EGFP cassette, a 900bp-long Sca I-Sma I
fragment containing a SAS internal ribosome entry site (IRES) was cut out from vector
pCIN4(5257) and ligated into the Sma I restriction site of pGEM.FRTOR1. The correct
orientation was confirmed by digestion with Xba I. Next, pGEM.FRTOR1 was digested
with BamH I, filled in and relegated to generate plasmid p31HR123-EGFPII. The latter
plasmid was digested with EcoR I and Sma I to obtain the first part of the EGFP cassette.
The second part of the EGFP gene was cut out with Sma I and Age I from p31HR123-
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EGFPII, which contained a second Sma I site downstream of the EcoR I site, and cloned
into the Sma I and BamH I sites of the pGEM.FRTOR1 to generate the new plasmid
pGEM-FRT-IRIS-EGFP. The second frt site was derived from pGEM-FRT. An EcoR I-
BamH I fragment was cloned into pBSIIKS to create pBS-FRT.  Next, the XhoI-fragment
derived from pGEM-FRT-IRIS-EGFP was inserted into pBS-FRT using the EcoR V site.
The new plasmid was named pGEM-FRT-IRIS-EGFP-FRT. The FRT-IRIS-EGFP-FRT
cassette was cut out with Cla I and cloned into filled-in EcoR I site of pGEMloxP to
introduce the 3rd loxP site. Next, the Not I/Aat II-digested pGEM-loxP-FRT-IRIS-EGFP-
FRT insert was cloned into pBS-M17-EcoR V using a Xba I restriction site. An EcoR V-
Sal I fragment from pDS#10 was ligated into the EcoR V/Sal I-digested vector pBS-
M17LA1 to generate pBS-M17LA2. The plasmid pMMneoFlox8 was opened with Not I
filled with a Xba I/Sca I insert derived from pDS#9. The new plasmid was called pMMneo-
flox-SA-M17. The latter plasmid was cut with Cla I and Xba I and the insert was ligated
into the Sma I restriction site of pBS- M17-LA2, thus generating pBS-M17-SA-neo-LA2.
Next, the pGEM-loxP-FRT-IRIS-EGFP-FRT was digested with EcoR V and the resulting
fragment was ligated into the EcoR V site of pBS-M17-SA-neo-LA2. Finally, a fragment
containing a thymindine kinase gene under the control of a phosphoglycerol kinase
promoter was cut out with EcoR I and Hind III from plasmid pNT and was ligated into the
BamHI restriction site of pBS-M17-SA-neo-LA2. The final targeting vector was named
pBS-M17-TV. Plasmid pBS-M17-TV was linearized with in a Sal I for the transfection of
embryonic stem cells.  Construction of the M17 targeting vector was done by Angela Egert
and Manolis Pasparakis.
B1.9 RNA isolation and RT-PCR
RNA was isolated from homogenized organs or single cell suspensions with Trizol
(Invitrogen/Gibco) according to manufacturer’s instructions. First strand synthesis was
performed with the Thermoscript RT-PCR System (Invitrogen/Gibco) using the primer P2R
annealing downstream of exon 6 between nt 1427 and 1453 of the published mouse Polk
cDNA sequence for analysis of Polk. An oligoT primer was used for the first-strand
synthesis of mRNA for the analysis of M17 expression. PCR amplification was performed
on 1/20 of the reverse-transcribed products.
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Table 2a: Primers used for RT-PCR
NAME SEQUENCE (5’-3’) LOCATION TAnn [°C]
DinBfor GCTAAGAGGCTCTGCCCACAAC Polk, exon 5 58
DinB-P2R CACTGAATGTCCTTTCAACACTCATGC Polk, exon 7 58
M17Seq1 ATGGGGAACTGTTTGCAGAGGACAACCAG M17, exon 1 57
M17Seq2 GGGAGCTGAAGTCATCCCTTCA M17, exon 3 57
M17Seq3 CTTTGGAGACTCTTGTCTGGC M17, exon 4 57
M17Seq4 GCTGTTGAAAGGCATGTGAGG M17, exon 5 57
m-b-actinB TCTTCATGGTGCTAGGAGCCA b-actin 57
m-b-actinT CCTAAGGCCAACCGTGAAAAG b-actin 57
Table 2b: Primer combinations and expected sizes of PCR products obtained by RT-PCR
GENE FIRST STRAND SYNTHESIS PRIMERS PRODUCT [bp]
Polk DinB-P2R DinBfor, DinBP2R 800
M17 oligo·dT M17Seq1, M17Seq2 156
M17 oligo·dT M17Seq1, M17Seq3 109
M17 oligo·dT M17Seq1, M17Seq4 431
B2 Cell Biology Experiments
B2.1 Embryonic Stem Cell Culture and Generation of Mice
Embryonic stem (ES) cells were cultured described by Pasparakis and Kollias or
Torres and Kuehn (Pasparakis and Kollias, 1995; Torres and Kuehn, 1997). ES cells were
grown in ES cell medium (DMEM supplemented with 15 % FCS, 1 mM sodium pyruvate, 2
mM L-glutamine, non-essential amino acids, 1:1000 diluted LIF containing supernatant,
and 0.1 mM 2-b-mercaptoethanol) on a layer of neomycin-resistant embryonic feeder (EF)
cells. The FCS had been tested previously for the promotion of ES cell growth and
maintenance of pluripotency. LIF was obtained from conditioned medium of the LIF-
secreting cell line L929. EF cells were cultured in EF medium (DMEM supplemented with
10% FCS, 1 mM sodium pyruvate, 2 mM L-glutamine, and non-essential amino acids) for
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a maximum of three passages. EF cells were mitotically inactivated with mitomycin-C (10
mg/ml for 2 h) 1 day before co-culture of ES and EF cells. ES cells were split before
reaching confluence using trypsin (0.05 % trypsin, 0.02 % EDTA; GIBCO-BRL),
supplemented the with 1% chicken serum.
For the generation of Polk-targeted ES cell clones, 1x107 129-derived IB10 ES
cells (Torres and Kühn, 1997) were transfected with 30 µg of Not I-linearized targeting
vector by electroporation (500 mF, 230 V) in RPMI1640 without Phenolred (Gibco). 24 h
post transfection, cells were subjected to selection with G418 (200µg/ml). Five days post
transfection, cells were additionally subjected to selection with Gancyclovir (2 µM).
Genomic DNA samples from double-resistant colonies were screened for homologous
recombination by BamH I digestion and subsequent Southern blot analysis using an
external 3’ probe. The probe was obtained by PCR amplification with the primers
DinProbeA-F2 and DinProbeA-Re using p129Xh9 as template. Co-integration of the third
loxP site was confirmed using the internal probe B by digesting the genomic DNA of the
targeted clones with Hind III. Probe B was excised from the plasmid pGEM-Ex6 using a
Taq I/Sal I double restriction digest. The absence of random integrantion of the targeting
vector was confirmed with a neomycin resistance gene-specific probe after digestion of
genomic DNA with BamH I. Two correctly targeted ES cell clones were injected into
blastocysts derived from CB.20 mice and transplanted into the uteri of CB.20 foster
mothers.
C57BL/6-derived Bruce 4 ES cells were used for the targeting of the M17 locus.
Cells were transfected with 30 mg of Sal I-linearized targeting vector and subsequently
subjected to G418 (170mg/ml) and Gancyclovir selection as described before.
Homologous recombinants were identified by Southern hybridization of an EcoRI genomic
restriction digest with the 5’ probe A. Probe A was derived from plasmid pDS10 by double
digestion with the Hinc II and Xba restriction enzymes. Co-integration of the third loxP site
was confirmed by EcoR I digestion of genomic DNA using probe B. To obtain the 3’ probe
B, plasmid pDS9 was cut with Sal I, and the new religated plasmid was cut again with
HinD III and subsequently Pst I to obtain a 1.3 kb fragment, which was used as probe.
Finally, Cre-mediated deletion was confirmed with the internal probe C. The latter probe
was generated by PCR with the primer pair MP57 and MP26 using plasmid pDS10 as
template. Chimeric mice were derived from two correctly target ES cell clones that had
been injected into blastocysts from CB.20 mice and transplanted into the uteri of CB.20
mice. M17 mice were generated by Angela Egert and Manolis Pasparakis.
Material and Methods34
B2.2 Preparation of Cell Suspensions from Lymphoid Organs
Isolated spleens, lymph nodes, Peyer’s patches were kept in RPMI medium
containing 3% FCS and squashed between frosted sides of two microscope slides to
obtain single cell suspensions. Bones were flushed with medium to extract bone marrow
cells and the peritoneal cavity was flushed with 10 ml of medium to recover cells.
Erythrocytes were lysed from spleen and bone marrow preparations by incubation in lysis
buffer for 3 min on ice (140 mM NH4Cl, 17 mM Tris-HCl pH7.65). Ex vivo isolated cells
were resuspended in B cell medium (DMEM, 5% FCS, 2 mM L-glutamine) and kept on
ice.
B2.3 Flow Cytometry
106 cells per sample were surface stained in 50 ml PBS, 1 % BSA, 0.01 % N3 with
combinations of fluorescein isothiocyanate (FITC), phycoerythrin (PE), Cy-Chrome (Cyc),
PERCP, or APC conjugated monoclonal antibodies (mAbs) for 15 min on ice. Stainings
involving biotinylated mAbs were followed by a second staining step with streptavidin
coupled to one of the fluorescent dyes. Subsequently, cells were washed and
resuspended with PBS/BSA/N3. Samples contained propidium iodide or Topro-3 for the
exclusion of dead cells. Flow cytometry was performed on a FACScan or FACSCalibur
and data were analyzed using CellQuest software (Becton Dickinson). All mAbs used in
this study were either commercially available or prepared in our laboratory by C. Uthoff-
Hachenberg, B. Hampel, and S. Willms. MAbs are listed in Table 3. Peanut agglutinin
(PNA) coupled to either FITC or biotin was purchased from Vector Laboraties (USA).
Table 3. List of antibodies used for flow cytometry
Specificity Clone Reference and Manufacturer
IgM R33-24.12 (Gruetzman, 1981), lab-made
IgD 1.3-5 (Roes et al., 1995), lab-made
IgMb MB86 (Nishikawa et al., 1986), lab-made
IgG2ab G12-47/30 (Seemann, 1981), lab-made
IgG2b R14-50 (Müller, 1983), lab-made
IgE 95.3 (Baniyash and Eshhar, 1984), lab-made
B220/ CD45R RA3-6B2 (Coffman, 1982), lab-made/Pharmingen
CD3e 145-211 (Leo et al., 1987), Pharmingen
CD4 GK.1.5/4 (Dialynas et al., 1983), Pharmingen
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CD5 53-7.3 (Ledbet ter  and Herzenberg, 1979),
Pharmingen
CD8 53-6.7 (Ledbet ter  and Herzenberg, 1979),
Pharmingen
CD19 1D3 (Krop et al., 1996), Pharmingen
CD21/CD35 7G6 (Kinoshita et al., 1988), Pharmingen
CD23 B3B4 (Rao et al., 1987), Pharmingen
CD24/HSA M1/69 Springer et al. 1978, Pharmingen
CD43 S7 (Gulley et al., 1988), Pharmingen
CD45Rb 16A (Bottomly et al., 1989), Pharmingen
CD69 H1.2F3 (Yokoyama et al., 1988), Pharmingen
CD95 (Fas) Jo2 Pharmingen
MHC class II M5/114 (Bhattacharya et al., 1981), Pharmingen
HSA 30F1 (Ledbetter and Herzenberg, 1979), lab-made
B2.4 Magnetic Cell Sorting
Specific cell populations were either enriched or depleted from a heterogeneous
cell suspension by magnetic cell sorting (MACS; Miltenyi Biotec, Bergisch Gladbach). The
cells were incubated with antibody-coupled microbeads (10 ml beads, 90 ml PBS/BSA/N3
per 107 cells) at 4 °C for 15 min and washed once in PBS/BSA/N3. Next, the cells were
applied to LD columns in a magnetic field (Miltenyi et al., 1990) and the columns were
washed 3 times with 3 ml of PBS/BSA/N3. MACS-purified cell populations were stained for
specific surface markers to assess the purity of the populations. MACS-purification
achieved typically a purity of 85%.
B2.5 Immunohistochemistry.
Immunostaining was performed on a BioTek Solutions TechMate 1000 automated
immunostainer (Ventana BioTek Systems, USA). Buffers, blocking solutions,
streptavidin/biotin complex reagents and chromogen were used as supplied in the Level 2
USA UltraStreptavidin Detection System purchased from Signet Laboratories (Dedham,
MA). Biotinylated secondary antibody was purchased from Vector Laboratories
(Burlingame, USA) Heat-induced epitope retrieval (HIER) buffer was obtained from
BioPath (Oklahoma City, USA). Paraffin sections were cut at 3 micron a rotary microtome,
mounted on positively charged glass slides (POP100 capillary gap slides, Ventana BioTek
Systems), and air dried overnight. Sections were deparaffinized and quenched with fresh
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3% hydrogen peroxide to inhibit endogenous tissue peroxidase activity. HEIR was then
performed using HIER buffer, pH 6.8 followed by incubation in unlabeled blocking serum
solution to block non-specific binding of secondary antibody. Sections were incubated for
4 hours either with a primary monoclonal antibody to mouse Polk protein at a 1:10 dilution
in antibody diluent, or with antibody diluent alone as a negative reagent control. Sections
were incubated with biotinylated goat antibodies to hamster immunoglobulin, with
horseradish peroxidase-conjugated Streptavidin-biotin complex, followed by
diaminobenzidine (DAB) and H2O2 in substrate buffer. Sections were counterstained with
Mayer's hematoxylin and examined by light microscopy. Immunohistochemistry was done
in collaboration with the Friedberg laboratory at the Southwestern Medical Center, Dallas,
USA.
B2.6 Immunofluoresence
 Mice were immunized with 50 µg NP-CG. 14 days post immunization, spleens or
Peyer’s patches were embedded in OTC and frozen in methyl butane that was cooled in
liquid nitrogen. The frozen organs were cut by the Pathology Core Facility of the
Brigham’s and Women Hospital, Boston, USA. Frozen sections were fixed in cold
acetone, air-dried and rehydrated in PBS and subsequently incubated with blocking buffer
(PBS containing 1% BSA and 5% goat serum) for 30 min. Next, the sections were
incubated with a mixture of either rat anti-mouse CD19 (Pharmingen) and biotinylated
PNA (Biosearch) or rat anti-mouse FDCM1 (Pharmingen) and biotinylated PNA for 30 min.
Following 3 washes in PBS, the sections were stained with a mixture of goat anti-mouse
IgG1-FITC and streptavidin-PE for 30 min. Sections were washed again in PBS, mounted
with Fluorotec medium, and examined by fluorescence microscopy.
B2.7 Sensitivity of Mouse Embryonic Fibroblasts to UV Radiation.
Mouse embryonic fibroblasts (MEFs) were isolated from day 13.5 embryos as
described in Meira et al. (Meira et al., 2001). Survival following exposure to UV radiation
was measured essentially as described by McWhir et al. (McWhir et al., 1993). Briefly,
cells at passage 6 were plated at a density of 3 x 105 cells/60-mm dish. The following day
the medium was aspirated and cells were irradiated with 0, 1.6, 3.2, 4.8 and 6.4 J/m2 of
UVC radiation at a fluence of 0.8 J m/2 s-1. Medium was replaced and the dishes were
incubated for 4 days. Cells were washed with PBS, fixed and stained with crystal violet.
The extent of cell growth and survival in individual dishes was determined by measuring
the incorporation of crystal violet in viable cells. Fixed cells were treated with 70% ethanol
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and the percentage of incorporation was determined by measuring optical density at 575
nm. Each dose point was performed in triplicate and results were confirmed in multiple
independent experiments. Survival relative to unirradiated controls at each dose was
calculated as the ratio of the mean OD575 of each dose/mean OD575 of unirradiated
controls, expressed as a percentage. Xpc-/- homozygous mutant MEFs were used as a
control (Cheo et al., 1997). The experiments were done in collaboration with Friedberg
laboratory at the Southwestern Medical Center, Dallas, USA.
B2.8 CFSE Labeling
Splenic B cells were enriched by the depletion of CD43+ cells using the MACS
system (CD43 magnetic beads, LD columns, Miltenyi). Cells in the flow-trough were spun
down, washed 3 times with PBS, and resuspended in 1 ml/107 cells of 2.5 µM CFSE (5
mM stock in DMSO, Molecular Probes) in PBS at 37 °C for 10 min (Lyons and Parish,
1994). The labeling reaction was stopped by addition of 10 ml ice-cold DMEM medium
containing 10% FCS. The cells were washed once in medium, plated in B cell medium at
2 x 106 cells per well in 12-well plates, and stimulated with 10 mg/ml aIgM mAb
(Pharmingen), 10 mg/ml aIgM mAb and 25 ng/ml IL-4 (R&D Systems), 20 µg/ml LPS, 20
µg/ml LPS and 25 ng/ml IL-4, 0.5µg/ml anti-CD40 mAb (clone HM40-3, Pharmingen), or
0.5µg/ml anti-CD40 mAb and 25 ng/ml IL-4. The cells were harvested three days after
stimulation and analyzed by flow cytometry.
B2.9 ELISA - Serum Analysis
Ig serum concentrations were determined by enzyme-linked immunosorbent
assays (ELISA) as described in Roes and Rajewsky (Roes and Rajewsky, 1993).
Microtiter plates (Costar) were coated with NP-BSA or antibodies of known isotype (see
table 4) in PBS at 4 °C over night, and subsequently blocked at room temperature for 30
min with PBS, 0.5 % BSA, 0.01 % N3, pH 7.2. Serially diluted sera samples were applied
to the wells and incubated at 4 °C over night. Next, the plates were incubated with a
secondary biotinylated anti-Ig antibody at 37 °C for 1 hour, followed by the incubation with
SA-conjugated alkaline phosphatase (AP, Roche) at room temperature for 30 min. The
amount of bound AP was detected by incubation with p-nitrophenylphosphate as substrate
(Roche). Following each incubation step, unbound antibodies or SA-conjugated AP were
removed by 3 washes with tapwater. The OD405 was measured with an ELISA-photometer
(Spectramax 340, Molecular Devices) and the relative antibody concentrations were
determined by comparison to a standard curve. Affinities of NP-specific IgG1 and Igl
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antibodies were determined by calculating the association constant as described by
Cumano and Rajewsky (Cumano and Rajewsky, 1986), following a method developed by
Herzenberg et al. (Herzenberg and Black, 1980).
Table 4. Reagents used to determine serum antibody isotypes.
Coating Biotin-Conjugate Specificity Standard
R33-24.12 goat anti-mouse IgM (SBA) IgM B1-8m
goat anti-mouse IgG1
(Sigma)
goat anti-mouse IgG1 (SBA) IgG1 N1G9
rat anti-mouse IgG2a
(Nordic)
goat anti-mouse IgG2a (SBA) IgG2aa 41.2-3
G12-47/30 G12-47/30 IgG2ab S43-10
R14-50 goat anti-mouse IgG2b (SBA) IgG2b D3-13F1
2E.6 goat anti-mouse IgG3 (SBA) IgG3 S24/63/63
goat anti-mouse IgA
(Sigma)
goat anti-mouse IgA (SBA) IgA IgA 233.1.3
95.3 rat anti-mouse IgE
(Pharmingen)
IgE B1-8e
187.1 R33-18-10.1 Igk S8
NP-BSA goat anti-mouse IgM (SBA) NP-IgM B1-8m
NP-BSA goat anti-mouse IgG1 (SBA) NP-IgG1 N1G9
NP-BSA goat anti-mouse l (SBA) -
LS136
NP-Igl N1G9
NP-BSA goat anti-mouse k (SBA) NP-Igk S8
B2.10 Analysis of Class Switch Recombination
B cells were purified from splenic single cell suspensions by MACS-depletion using
anti-CD43 microbeads (Miltenyi Biotech). Subsequently, the cells were cultured at a
concentration of 106 cells/ml and stimulated with either 20 µg/ml LPS alone, 20µg/ml LPS
and 2ng/ml IFN-g (R&D Systems), 20µg/ml LPS and 2ng/ml TGFg (R&D Systems), or
0.5µg/ml anti-CD40 mAb (clone HM40-3, Pharmingen) and 25 ng/ml IL-4 (R&D Systems).
Cells were cultured for 5 days during which the cell numbers were kept constant by
addition of fresh medium. The percentage of class switched cells was determined on day
4 or day 5 by flow cytometry.
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B2.11 Somatic Hypermutation Analysis
14 days post immunization with 100 mg NP-CG, splenic GC B cells were enriched
by magnetic cell seperation using the MACS system (Miltenyi Biotech). After erythocyte
lysis, splenocytes were first incubated with an anti-IgD-biotin mAb (clone 1.3-5, ref.),
followed by a combination of streptavidin- and anti-CD43-microbeads (Miltenyi Biotech).
The cells were then subjected to an LD separation column (Miltenyi Biotech). GC B cells
(B220+PNAhigh) were purified from the flow through by fluorescence-assisted cell sorting
(FACS) using an anti-B220-fluorecein isothiocyanate (FITC) mAb (clone R33-24.12, ref.)
and peanut agglutinin (PNA) coupled to phycoerythrin (PE). Likewise, naïve B cells
(B220+IgD+) were isolated from the eluate with anti-IgD-FITC (clone 1.3-5) and anti-B220-
PE (clone R33.24-12) mAbs. Cells were sorted on a FACS 440 cell sorter (Becton
Dieckinson). Alternatively, GC B cells from spleen or Peyer’s patches were purified
directly after incubation with PNA-FITC, anti-Fas-PE mAb and anti-B220-Cyc mAb on a
FACSVantage cell sorter (Becton Dickinson) into a naïve fraction (B200+PNAlowFaslow) and
a GC fraction (B220+PNAhighFashigh).
Sorted cell populations were lysed in 50 µl/105 cells of 10 mM Tris•HCl and 0 .5
mg/ml proteinase K (Roche) for 2.5 h at 50∞C, followed by the denaturation of proteinase
K at 95∞C for 10 min. For the analysis of somatic mutations, PCR fragments were
obtained using primer pair J558Fr3 5’-CAGCCTGACATCTGAGGACTCTGC and JHCHint
5’-CTCCACCAGACCTCTCTAGACAGC. Primer J558Fr3 anneals in the framework 3
region of most J558 V genes and primer JHCHint hybridizes in the intron 3’ of exon JH4
(Jolly et al., 1997). PCR amplification was done with a 60/1 mixture of Taq and Pfu DNA
polymerase from 20 µl of cell lysate in a total volume of 50 µl (30 s at 95∞C, 30 s at 65∞C
and 2 min at 72∞C, 32 cycles). Alternatively, the Expand High Fidelity Kit (Roche) was
used. Subsequently, the PCR products were purified with a QiaEx II Kit (Qiagen) and
incubated for 15 min at 72°C with Taq polymerase to produce A-overhangs. PCR products
were ligated into the A/T-cloning vector pGEM-T easy (Promega). Plasmids were isolated
using the GFX Micro Plasmid Prep Kit (Pharmacia) and sequenced by dye-terminated
automatic sequencing (Applied Biosystems) using primers JHCHint and JHCHj.2 (5'-
ACTATCCCTCCAGCCATAGG). A 500 nt stretch of intron sequence was analyzed with
the GeneJockey II software (Biosoft). Mutation frequencies were calculated as the total
number of mutations devided by the number of sequenced nucleotides in mutated
sequences.
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B3 Mouse Experiments
Mouse experimental procedures like vasectomy of males, tail bleeding as well as
breeding of foster mothers and the general handling, marking of mice were performed
according to Hogan (Hogan et al., 1987) and Silver (Silver, 1995). Blastocyst injection of
ES cells was performed by Angela Egert and Anke Leinhaas.
B3.1 Mice
C57BL/6 and 129/Sv mice were obtained from Bomholtgard, Charles River, Harlan
Winkelmann, or Jackson Laboratories. CB20 mice were taken from breedings in our
animal facility. Deleter mice (Schwenk et al., 1995) were intercrossed with chimeras
harboring the loxP-flanked Polk allele to generate a mouse strain deficient of Polk. Polk-/-
mice were kept on a mixed genetic background of 129/Ola and C57BL/6. Polm-/-and Poll-/-
mice were generated in our laboratory by Gloria Esposito in collaboration with Luis Blanco
(Universidad Autonoma de Madrid, Madrid, Spain). Polm-/- mice were kept on a C57BL/6
genetic background, while Poll-/- mice were kept on 129/Ola genetic background. To
generate compound mutants of DNA polymerase-deficient mice, Polk-/- mice were crossed
with either Polm-/- or Poll-/- mice to generate Polk-/-Polm-/- and Polk-/-Poll-/-Poli-/- strains. The
latter two strains were intercrossed to produce compound mutants deficient of Polk, Polm,
Poll, and Poli. M17-/- mice were generated in our laboratory by Angela Egert and Manolis
Pasperakis. Mice containing the floxed M17 allele were intercrossed with Deleter-Cre
mice. Mice carrying a deleted M17 allele were crossed to homozygosity and kept on a
pure C57BL/6 genetic background.
All mice used in this study were derived from single ES cell clones. Mice were at
an age of 8 to 14 weeks at the time of analysis. One analysis of SHM in Polk-/- mice was
performed with 8 month-old mice derived from an independent ES cell clone (referred to
as Polk-/-*).
B3.2 Immunizations
Primary T-dependent antigen responses were induced with alum-precipitated NP-
CG (4-hydroxy-3-nitrophenylacetyl coupled to chicken g-globulin) (Weiss and Rajewsky,
1990). The immunogen was prepared by mixing of NP-CG (1 mg/ml in PBS) and 10 %
KAl(SO4)2 in a volume of 1:1. The solution was adjusted to pH 6.5 with 5N NaOH and kept
on ice for 30 min. After the incubation, the precipitate was washed three times in PBS and
resuspended in PBS. Mice were immunized by intra-peritoneal injections with 10, 50 or
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100 mg NP16-36-CG in a volume of 200 m l. For secondary immunizations, mice were
injected intra-peritoneally with 10 mg NP-CG without alum in 200 ml PBS.
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C. RESULTS
C1 The Function of DNA Polymerase k
C1.1 Generation of Polk-Deficient Mice
To investigate the role Polk in the mouse, I generated a conditional Polk
allele by gene targeting. I flanked exon 6 of the Polk (DinB1) gene with loxP sites
rendering it susceptible to Cre recombinase-mediated deletion. Additionally, I
introduced a loxP-flanked neomycin resistance (neor) gene as selection marker.
Exon 6 was chosen for two reasons. First, it contains two essential catalytic
residues: Aspartate 197 and Glutamate 198. Replacement of these two amino
acids by alanine residues results in a complete loss of the DNA polymerase
function in vitro (Ogi et al., 1999; Ohashi et al., 2000). Second, mRNA splicing
from exon 5 to exon 7 leads to a frame-shift mutation. The wild-type Polk  locus,
the modified locus after homologous recombination with the targeting vector and
the locus after Cre-mediated recombination are depicted in Figure 8A. Two
independent embryonic stem (ES) cell clones containing the loxP-flanked exon 6
and the neor gene were used to generate chimeric mice; both transmitted the
targeted allele into the germline. Conventional Polk knock-out mice were
generated by crossing the chimeras to a deleter mouse (Figure 8B). Mice
homozygous for the deletion of exon 6 are viable, present at the expected
Mendelian ratio and do not exhibit obvious abnormalities. In contrast to Polz
(Bemark et al., 2000; Esposito et al., 2000a; Wittschieben et al., 2000) and Polb
(Gu et al., 1994b; Sugo et al., 2000), lack of Polk protein does not interfere with
embryonic development. To create a conditional allele for Polk, I deleted the neor
gene in the two targeted ES cell clones in vitro by transfection of a Cre-expressing
plasmid. Two ES cell clones deficient of the neor gene but retaining the loxP-
flanked (floxed) exon were used to generate chimeras, which both transmitted the
floxed Polk  (Polk fl) allele into the germline (not shown).
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Figure 8. Generation of Polk-/- mice. (A) Schematic representation of the gene targeting
in the Polk locus by homologous recombination. 129/Ola-derived ES cells were targeted
with a vector containing the loxP-flanked exon 6 and a neomycyin resistance cassette for
positive selection. A thymidine kinase gene was used to select against random integration
of the vector. ES cells were screened by Southern blot of BamH I-digested DNA with the
external  probe A located at the 5’ end. Rectangles represent coding DNA, filled triangles
indicate loxP sites, and bold lines show regions of homology. E, exon; B, BamH I site; tk,
thymidine kinase gene; neor, neomycin resistance gene. Only exons 5 and 6 of the wild-
type locus are shown. (B) Cre-mediated deletion of exon 6 and the neomycin resistance
cassette. A Southern blot of BamH I-digested tail DNA from wild-type, heterozygous and
homozygous mice, respectively, is shown. Probe B containing exon 5 of the Polk locus
was used. The wild-type fragment migrates at 9.9 kb and the fragment from the targeted
locus migrates at 5.2 kb.
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To confirm the inactivation of the Polk   gene, I amplified Polk  transcripts
from testis by RT-PCR using primers spanning exon 6. As shown in Figure 9A,
cDNA from Polk+/+ mice gave rise to two alternative splice-products. In contrast,
cDNA from Polk -/- mice gave rise to one PCR product only, which was shorter than
the larger wild-type product and consistent with the lack 153 basepairs
corresponding to exon 6 in the mRNA (Figure 9A), as confirmed by sequencing
(not shown). Additionally, Northern blot analysis using equal amounts of mRNA
from wild-type and mutant mice revealed that the intensity of the band from the
latter was 5 times less than the band from the wild-type sample (Figure 9B). The
presence of a frameshift mutation leading to premature stop codons presumably
renders mRNA lacking exon 6 less stable than wild-type mRNA.
In collaboration with Errol Friedberg and Valerie Gerlach (E. C. F. and V.
G., Southwestern Medical Center, Dallas, TX, USA), I analyzed histological
sections of mouse testis by immunohistochemistry to confirm the absence of Polk
protein in the mutant mice. Frozen sections of testis from either wild-type or Polk-
deficient mice were incubated with a monoclonal antibody against human Polk
protein. Polk protein was mainly localized in the nuclei of spermatocytes and round
spermatids of the seminiferous tubules in wild-type animals (Figure 9C). In
contrast, no signal could be detected in mice homozygous for the deletion of exon
6 (Figure 9C).
C1.2 Polk-Deficient Mice are Fertile
As shown in Figure 7C, the overall histological structure of the testis from
Polk-deficient mice is indistinguishable from that of wild-type controls. I also failed
to detect abnormalities in the shape and mobility of sperm cells from mice lacking
Polk. Furthermore, both male and female Polk mutants are fertile and the litter size
does not differ from wild-type mice (data not shown). At the present time, the
functional significance of the high levels of tissue-specific expression of Polk in the
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Figure 9. Polk-/- mice are unable to express Polk. (A) RT-PCR of Polk+/+,   Polk+/-, and
Polk-/- mice with primers annealing in exon 5 and downstream of exon 6, respectively. (B)
Northern hybridization of equal amounts of RNA from Polk+/+ and Polk-/-, mice with a Polk-
specific probe spanning nucleotide 483 to nucleotide 1493 of the cDNA sequence. (C)
Immunohistology of sections from testis with a monoclonal antibody against human Polk.
Shown are sections from a wild-type mouse (left panel) and from a Polk-deficient mouse
(right panel). Figure 9B and C was done in collaboration with E. C. F. and V. G.
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mouse testis is not clear. Several other error-prone DNA polymerases are also
highly expressed in the testis. In particular, Poll  and Poli share a similar
expression pattern with Polk (Garcia-Diaz et al., 2000; McDonald et al., 1999). It
was therefore conceivable that Polk, Poll and Poli serve overlapping functions in
the testis and in Polk-/- mice the other two polymerases may compensate for the
loss of Polk activity. However, compound mutants deficient of Polk, Poll, and Poli
are fertile and produce litters of normal size (data not shown).
C1.3 Polk-Deficient Embryonic Fibroblasts are Sensitive to Killing by UV
Radiation
Base damage can stall or arrest normal DNA replication. Polymerase k is
one of multiple specialized DNA polymerases that may be used in cells to bypass
such sites of DNA damage. Purified Polk is not able to bypass thymine dimers, [6-
4] photoproducts (quantitatively major photoproducts produced by UV radiation) or
cisplatin lesions in vitro (Gerlach et al., 2001). However, the purified enzyme is
able to extend from mismatched termini opposite of thymine dimers (Washington
et al., 2002) and can bypass thymine glycol lesions in vitro (Fischhaber et al.,
2002). Thymine glycols are a form of oxidized thymine that can be produced by
various treatments of cells, including exposure to UV radiation. Therefore, I
compared the sensitivity of embryonic fibroblasts (MEFs) from homozygous
mutant and wild-type Polk mice to UV light (in collaboration with E. C. F. and V.
G.). As shown in Figure 10, the Polk-deficient cells are moderately sensitive to UV
radiation as measured by crystal violet staining and are comparable to MEFs from
homozygous mutant Xpc-/- mice defective in genome-wide DNA repair but
proficient in transcription-coupled nucleotide excision repair (Cheo et al., 1997).
These results indicate that in the absence of Polk, some form of UV radiation
damage (possibly thymine glycol) results in cell death.
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Figure 10. Polk-deficient cells are abnormally sensitive to killing following exposure
to UV radiation. Mouse embryonic fibroblasts were irradiated with UV light. The survival
of the cells was scored four days later by crystal violet staining. Closed circles Polk+/+
MEFs; closed triangles, Polk-/- MEFs; open squares Xpc-/- MEFs.
C1.4 Polk-Deficient Mice Show Normal B and T Cell Compartments
Cellular proliferation or viability may be impaired by the absence of a DNA
polymerase. Hence, I investigated whether Polk-deficiency affects the size of B
and T cell compartments. B and T cell development occurs normally in Polk-
deficient mice (not shown). Likewise, B and T cells subsets are present at normal
numbers in the spleen (Figure 11A). T cells subsets are also present in normal
numbers in the spleen (data not shown).
GC B cells represent a highly proliferating cell population. They may be
particularly affected by the absence of Polk. Polk-deficient mice and wild-type
controls were immunized with NP-CG and monitored for the presence of GC B
UV dose (J/m2)
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Figure 11. B cell populations in spleen (A) and GC B cells in spleen, mesenteric
lymphnodes, and Peyer’s patches (B). (A) Splenocytes were stained with a-IgM and a-
IgD mAbs to visualize IgMhighIgDlow immature and mature IgMlowIgDhigh B cell populations.
CD21highCD23low MZ and follicular CD21lowCD23high B cells are shown by staining with a-
CD21 and a-CD23 mAbs. Only CD19+ cells are shown. (B) Mice were immunized with 50
mg NP-CG and analyzed for the presence of CD19+PNA+Fas+ GC B cells 14 days post
immunization. Only CD19+ cells are shown. SP, spleen; MLN, mesenteric lymph nodes;
PP, Peyer’s patches.
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cells 14 days later. However, I did not observe any significant variations between
the two cohorts with respect to CD19+Fas+PNAhigh GC B cells in spleen,
mesenteric lymph nodes, and Peyer’s patches (Figure 11B). Thus, Polk is not
required for B and T cell development and is unlikely to influence cell proliferation
during an immune response.
C1.5 Polk-Deficient Mice respond to the T Cell-Dependent Antigen NP-CG
and Display Normal Serum Ig Titers
 The mechanisms of SHM and CSR share common elements (Ehrenstein
and Neuberger, 1999; Muramatsu et al., 2000; Nagaoka et al., 2002; Reina-San-
Martin et al., 2003; Revy et al., 2000). Therefore, I measured the serum levels of
the different Ig isotypes of Polk-deficient mice and wild-type controls by ELISA to
investigate whether in Polk-deficient mice can undergo CSR and form antibody-
secreting plasma cells. As shown in Figure 12A, Polk-deficient mice are able to
generate antibodies of all isotypes at levels comparable to wild-type controls.
Hence, Polk-deficiency is unlikely to affect CSR and the generation of plasma
cells.
Next, I investigated whether Polk-/- B cells are able to mount an efficient T
cell-dependent immune response and differentiate into plasma cells secreting
antigen-specific IgG1. Groups of four age-matched mice were immunized with (4-
hydroxy-3-nitrophenyl) acetyl-chicken globulin (NP-CG) and the levels of NP-
specific IgG1 were determined 14 days later. The serum levels of NP-specific IgG1
are similar in Polk-/-, Polk+/-, Polk+/+ and Polkfl/fl mice (Figure 12A). Thus, Polk-
deficient B cells are able to participate in T-cell dependent immune responses
similarly to control B cells and efficiently secrete antigen-specific antibodies.
C1.6 Polk-Deficient GC B Cells Mutate Their Ig Genes Efficiently
To investigate whether Polk is involved in SHM of Ig genes, groups of 7-9
week (2 Polk-/-, 2 Polk+/-  and 1 Polkfl/fl animals) and 8 month (2 Polk-/- mice,
designated Polk-/-*) old mice were immunized with NP-CG. 14 days post
immunization, GC B cells were isolated and analyzed for the level and
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Figure 12. Antibody titers in serum (A) and antibody response to NP-CG (B) of Polk-
deficient mice. (A) Antibody titers in the serum of unimmunized wild-type (closed circle)
and Polk-deficient (open circle) mice as determined by ELISA. Black bars indicate the
geometric means. (B) Antibody response of Polk-deficient mice and control mice to NP-
GC. Mice were immunized with NP-CG and the serum concentrations of NP-specific IgG1
were measured 14 days post immunization in an ELISA assay. Each dot represents the
serum titer of an individual mouse. Polk genotypes are as indicated.
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pattern of somatic mutations. To study the intrinsic features of the hypermutation
process, I analyzed the accumulation of mutations in the intronic sequence
downstream of the rearranged V gene as previously described (Jolly et al., 1997).
GC B cells (B220+PNA+) and naïve B cells (B220+PNA-IgD+) were isolated by
FACS-purification from spleens of immunized Polk-/-, Polk+/-, and Polkfl/fl mice
(spleens from age matched mice with identical genotype were pooled). All mice
responded to the NP-CG immunization, as demonstrated by the elevated levels of
NP-specific IgG1 antibodies in the blood (data not shown).
Genomic DNA from the FACS-purified cells was PCR-amplified from 40,000
cell equivalents using primers annealing in the framework region 3 of most
members of the J558 V gene family (Jolly et al., 1997) and in the intron
downstream of the JH4 gene segment (see Materials and Methods), thus covering
a large fraction of rearranged V genes. PCR products were cloned and
sequenced. All sequences analyzed showed unique rearrangements.
In agreement with previous analyses (Esposito et al., 2000b; Gu et al.,
1991), the vast majority of the sequences derived from the naïve B cell population
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Figure 13. SHM patterns in Polk-deficient mice. Patterns of nucleotide exchanges in a
500 bp-long region in the intron downstream of the rearranged VHDHJH4 joints of GC B
cells derived from Polkfl/fl, Polk+/-, and Polk--/- mice, respectively. GC B cells were isolated
14 days post immunization with NP-CG. Following cell lysis, a 600 bp fragment was PCR-
amplified from 40.000 cell equivalents using a primer pair that anneals in the framework 3
region of most J558 V genes and in the intron downstream of JH4 gene segment. All
values are shown in %. n, the number of mutations; Ts., transitions; Tv., transversions;
Ts./Tv., the transions over transversions ratio. Polk-/-* mice: 8 months old.
were unmutated (Table 4). Somatic mutations were present in most sequences
derived from the Polk-/-, Polk+/-, and Polkfl/fl GC B cell populations. Sequences
bearing one or more mutations were included in the analysis of mutational
patterns. Both the number of mutations per sequence and the average mutation
frequency (≈ 1%) of the mutated clones were similar (Table 5). The mutational
patterns of the JH-CH introns derived from the Polk
-/- mice did not reveal significant
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differences from the patterns derived from the control mice (Figure. 13). Excluding
respectively the Gs in the second position of the intrinsic hot spot motifs RGYW
(Rogozin and Kolchanov, 1992) or all mutations present at hotspots (I defined all
RGYW motifs in which at least 15% of the sequences presented 1 or more
mutations, as hot spots), the mutational patterns did not change significantly (data
not shown). Adenine was still the most frequently mutated base and the ratio of
transitions over transversions remained essentially the same. Likewise, I did not
observe any differences with respect to the frequency of frameshift or tandem
mutations (data not shown). I therefore conclude that the Polk-/- mice mutate their
Ig genes normally.
C1.7 SHM in DNA Polymerase Polk-/-Poll-/-Poli-/- Compound Mutants
SHM in mouse mutants deficient of Poll or Poli is normal (Bertocci et al.,
2002; McDonald et al., 2003). To investigate whether error-prone DNA
polymerases can substitute for each other’s function, I intercrossed Polk-/- mice
with Poll -/- and P o l i -/- to generate P o lk-/-Poll-/-Poli- / -  compound mutants.
Polk-/-Poll-/-Poli-/- mice are viable and show no obvious abnormalities. Moreover,
both male and female mice are fertile.
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Naïve and GC B cell populations were isolated by FACS-purification from the
Peyer’s patches of pairs of unimmunized wild-type and Polk-/-Poll-/-Poli-/- mice. As
expected, naïve B cells harbored very few mutations (0.02%) and reflected the
frequency of mutations introduced by PCR. In contrast, somatic mutations were
present in the majority of sequences derived from GC B cell populations of Polk-/-
Poll-/-Poli-/- mice and wild-type controls. Sequences bearing one or more mutations
were included in the analysis of mutational patterns. Both the number of mutations
per sequence and the average mutation frequency (1.1 and 0.9%, respectively) of
the mutated clones were similar (Table 6). The mutational patterns of the JH-CH
introns derived from the Polk -/-Poll-/-Poli-/- mice did not reveal significant
differences from the patterns derived from the control mice (Figure. 14). In
Figure 14. SHM patterns in Polk -/-Poll-/-Poli-/--deficient mice. Patterns of nucleotide
exchanges in a 500 bp-long region in the intron downstream of the rearranged VHDHJH4
joints of GC B cells derived from Polk-/-Poll-/-Poli-/- mice, respectively. GC B cells were
isolated from Peyer’s patches. Following cell lysis, a 600 bp fragment was PCR-amplified
from 40.000 cell equivalents using a primer pair that anneals in the framework 3 region of
most J558 V genes and in the intron downstream of JH4 gene segment. All values are
shown in %. n, the number of mutations; Ts., transitions; Tv., transversions; Ts./Tv., the
transions over transversions ratio.
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addition, the ratio of transitions versus transversions in sequences derived from
Polk-/-Poll-/-Poli-/- mice did not change dramatially. Excluding respectively the Gs in
the second position of the intrinsic hot spot motifs RGYW, the mutational patterns
did not change significantly (data not shown). Adenine was still the most frequently
mutated base and the ratio of transitions over transversions remained essentially
the same. Likewise, I did not observe any differences with respect to the frequency
of frameshift or tandem mutations (data not shown). I therefore conclude that the
Polk-/-Poll-/-Poli-/- mice efficiently mutate their Ig genes.
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C2 The Function of M17 in the Immune System
C2.1 Generation of M17-Deficient Mice
To investigate the in vivo function of M17, the M17  locus had been
previously inactivated in the mouse by conditional gene targeting (Angela Egert
and Manolis Pasparakis, Cologne, Germany). A neomycin resistance (neor) gene
flanked by loxP sites was introduced 5’ of exon 4 and an additional loxP site 3’ of
exon 5, thus enabling the deletion of those exons by Cre-mediated recombination.
In addition, a cassette containing a splice-acceptor site, an internal ribosome entry
site (IRES) and a green fluorescence protein gene was introduced 3’ of exon 5 to
mark cells having undergone Cre-mediated deletion. Deletion of exon 4 and 5
removes most of the coding sequence of M17 gene including the ITAM motif and
the putative C-terminal lipid-binding domain plus the 3’ UTR. This strategy likely
results in a nonfunctional M17 gene. The wild-type locus, the targeting vector and
the modified locus after homologous recombination with the targeting vector and
argeted locus after Cre-mediated recombination are depicted in Figure 15A. Two
independently targeted ES cell clones were injected into blastocysts to generate
chimeric animals. Chimeric mice that transmitted the targeted allele into the germ
line were crossed to the Cre-deleter strain to delete exons 4 and 5 in vivo.
Successful deletion was confirmed by Southern blot of Bgl II or EcoR I-digested
tail DNA of the offspring (Figure 15B). Mice homozygous for the deletion of M17
are viable, born at a Mendelian ratios and display no obvious abnormalities.
M17 is predominantly expressed in GC B cells. To confirm the inactivation
of the M17 gene on the level of RNA transcripts, I immunized M17-/- mice and wild-
type controls with NP-CG and isolated CD19+Fas+PNAhigh GC B cells 14 days later
by flow cytometry. I purified RNA from these cells for analysis by RT-PCR using a
primer pair that anneals in exon 1 and 4 of the M17 mRNA, respectively. In
contrast to M17+/+ mice, amplification from equal amounts of GC B cell-derived
cDNA from M17-/- mice did not yield a PCR product (Figure 15C).
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Figure 15. Generation of M17-/- mice. (A) Schematic representation of the gene
targeting in the M17 locus by homologous recombination. C57BL/6-derived ES cells were
targeted with a vector containing the loxP-flanked exons 4 and 5, a frt-flanked IRES-gfp
cassette, and a neomycin resistance cassette for positve selection. Negative selection of
clones harboring randomly integrated vectors was mediated by a thymindine kinase
gene. Only exons 3-5 are shown. Rectangles, coding DNA; filled triangles, loxP sites;
ovals, frt sites; RI, EcoR I; BII, Bgl II. Bold lines indicate regions of homology and
Southern probes are shown as thin black lines under the wild-type locus. (B) Successful
homologous recombination was identified by Southern blot of EcoR I-digested genomic
ES cell DNA and a probe located at the 5’ of M17  exon 3. The wild-type fragment
migrates at 6.9 kb, while the fragment from the targeted locus migrates at 4.6 kb. Cre-
mediated deletion of M17 exon 4 and 5 was confirmed by Southern blot of Bgl II-digested
genomic DNA using a probe located 5’ of exon 4. The wild-type fragment migrates at 2.1
kb and the fragment of the deleted locus migrates at 1.0 kb. (C) Confirmation of the
successful inactivation of M17 by RT-PCR. RNA was isolated from sorted CD19+PNA-
Fas- naïve B cells (N) or CD19+PNA+Fas+ GC B cells from either M17+/+ or M17-/- mice
and reverse transcribed using an oligoT primer.  PCR products were amplified with
primers annealing either in exons 1 and 4 (primer M17 1/4) or in exons 1 and 3 (M17 1/3).
Intron-spanning primers annealing in the b-actin gene were used as loading control. (D)
Sequence comparison of the larger and smaller RT-PCR product amplified with the
primer pair annealing in M17 exons 1 and 4. The smaller PCR product is identical with
the published cDNA sequence of M17, while the larger product reveals a novel exon
located downstream of exon 1. The size and location of the new exon can account for the
discrepancy between HGAL and M17 at the 5’ end of the cDNA.
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PCR amplification with a reverse primer that hybridizes in exon 3 also failed to
yield a PCR product from cDNA of M17-/- mice, suggesting a destabilized mRNA of
the inactivated M17 gene and the IRES-GFP  cassette (data not shown).
Surprisingly, the PCR using cDNA from wild-type mice revealed the presence of
two products. The smaller one was consistent with the expected size of 155 bp.
Sequencing of the larger product demonstrated the existence of a previously
unknown exon of 66 bp that is located between exon 1 and 2 (Figure 15D). M17
and HGAL differ most significantly at the N-terminus, with the cDNA of HGAL
being longer than the one of M17. The discovery of the new exon helps to account
for this discrepancy. A sequence analysis of the new exon on both the DNA and
protein level did not reveal any homologies to other known DNA or protein
sequences besides HGAL.
C2.2 M17 mRNA is Upregulated by IL-4
Interleukin-4 (IL-4) induces the expression of HGAL in peripheral blood B
lymphocytes. The M17  gene contains two putative STAT6  binding sites,
suggesting similar regulation and response to IL-4. To determine whether the
expression of M17 is also regulated by IL-4, I stimulated MACS-purified B cells in
vitro with either lipopolysaccaride (LPS) or a monoclonal antibody (mAb) directed
against CD40 in the absence or presence of IL-4. I  isolated total RNA from equal
numbers of cells 48 hours later, and determined M17 mRNA expression by RT-
PCR using intron-spanning primers specific for the M17 and b-Actin genes. As
expected, unstimulated or LPS-stimulated cells did not express M17. Stimulation
with an aCD40 mAb alone also failed to induce M17 expression. In contrast,
activation of the cells with LPS or aCD40 mAb in the presence of IL-4 upregulated
the expression of M17 mRNA (Figure 16). Thus, IL-4 induces the expression of
M17 mRNA in LPS or aCD40-activated B cells in vitro. The M17 gene appears to
be regulated in a fashion similar to the HGAL gene and M17 may be involved in IL-
4 induced immune responses in vivo.
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Figure 16. M17 is upregulated by IL-4. Isolated splenocytes were MACS-depleted of
CD43+ cells and subsequently activated with the indicated stimuli. Following isolation of
total RNA 48 h later, RT-PCR was performed using intron-spanning primers for the M17
and b-Actin genes. A representative experiment is shown.
C2.3 B and T Cell Compartments in M17-Deficient Mice
The predominant sites of M17 mRNA expression in vivo are the GCs.
However, expression of M17 mRNA is also found in developing B cells in the bone
marrow (Christoph, 1993). The analysis by flow cytometry of the bone marrow-
derived cells did not reveal differences in absolute cell numbers or proportions of
major subsets of developing B cells, indicating that M17 is dispensable for B cell
development (data not shown).
In the peripheral lymphoid organs, the number of total cells in spleen and
mesenteric lymph nodes was equivalent in M17-deficient mice and wild-type
control mice. In contrast, the number of total cells in Peyer’s patches is reduced by
2-3 fold (Figure 17A). The reduction of total cells in the latter organ reflected both a
reduced number of Peyer’s patches per mouse (5.1 ± 1.3 versus 7.8 ± 1.1 Peyer’s
patches in M17-/- and M17+/+ mice, respectively) and a reduced size of some but
GC
M17
b-Actin
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Figure 17.  Cell numbers and B cell subsets in peripheral lymphoid organs. (A) The
total number of cells in peripheral lymphoid organs. (B) Splenocytes were stained with a-
IgM and a-IgD mAbs to identify IgMhighIgDlow immature and mature IgMlowIgDhigh B cell
populations. CD21highCD23low MZ and follicular CD21lowCD23high B cells are shown by
staining with a-CD21 and a-CD23 mAbs. Only CD19+ cells are shown. (C) Mice were
immunized with 50 mg NP-CG and analyzed for the presence of CD19+PNA+Fas+ GC B
cells 14 days post immunization. Only CD19+ cells are shown Numbers, average in % plus
standard deviation. SP, spleen; MLN, mesenteric lymph nodes; PP, Peyer’s patches.
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not all Peyer’s patches in M17-/- animals.
The proportions of splenic immature IgMhighIgDlow and mature IgMlowIgDhigh
B cell populations were comparable to wild-type controls and the ratio of
CD21highCD23low MZ B cells to CD21lowCD23high follicular B cells was unchanged in
M17-/- mice (Figure 17B). CD4+ and CD8+ T cells were also present at wild-type
levels. Although the number of total cells was reduced in Peyer’s patches, the
proportion of total B cells stayed the same. The ratio of B and T cells was
unchanged and the proportions of B cell subsets were normal when compared to
wild-type mice (not shown).
To analyze the proportions of CD19+Fas+PNAhigh GC B cells in M17-/- mice
and wild-type controls, the mice were immunized with 50 mg NP-CG and the
percentage of GC B cells was determined 14 days later. The proportion of
CD19+Fas+PNAhigh GC B cells in the spleen and mesenteric lymph nodes is not
significantly changed in M17-deficient mice (Figure 17C). Despite the general
reduction of total cells in Peyer’s patches, GC B cells are still generated efficiently
in this compartment. Hence, M17 is dispensable for the generation and
maintenance of the major B and T cell populations in bone marrow, spleen, and
mesenteric lymph nodes, but surprisingly affects the number of B and T cells in
Peyer’s patches. M17 is not essential for the generation of GC B cells.
C2.4 Stimulated M17-Deficient B Cells Proliferate Normally
To analyze the proliferative capacity of M17-deficient B cells, I isolated
splenic B cells from M17-/- mice and wild-type controls by MACS-depletion of
CD43+ cells and labeled the B cells with the protein-binding dye CFSE to study cell
division. Following CFSE-labeling, the cells were stimulated with either LPS or an
aCD40 mAb in the presence of IL-4. Cell proliferation was measured three days
post stimulation by flow cytometry. M17-deficient B cells proliferate at levels
comparable to wild-type cells upon LPS or CD40 stimulation in the presence of IL-
4 (Figure 18). Stimulation with aIgM in the presence IL-4 results in a similar
outcome (data not shown). The measurement of cell proliferation by cell counting
gave similar results. Therefore, M17 is dispensable for efficient cell proliferation in
vitro.
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C2.5 Germinal Center Architecture Is Not Affected in M17-Deficient Mice
         Next, I studied cryosections from spleen and Peyer’s patches by
immunofluorescence to analyze the impact of M17-deficiency on the architecture
of the GCs. Spleens were isolated 14 days after the immunization of either wild-
type or M17-deficient mice with NP-CG. Frozen splenic sections were incubated
with PNA and mAbs against CD19 or FDCM1 coupled to fluorescent conjugates to
visualize B cells follicles, GC B cells and the network of follicular dendritic cells
(FDCs), respectively. As shown in Figure 19A, M17-deficient are able to develop
GCs (PNA+ cells, red) and B cell follicles (CD19+ cells, green) comparable in size
and shape to wild-type animals. M17-deficient mice also show a polarized network
of FDCs (FDCM1+ cells, green), highlighting the GC light zone containing
centrocytes.
Figure 18. Proliferation of M17-/- B cell in vitro. Splenocytes were depleted of CD43+
cells, labeled with CFSE, and stimulated with an aCD40 mAb plus IL-4 or LPS plus IL-4.
After three days of culture, cell proliferation was determined by flow cytometry. All
histrograms represent CD19+ B cells. A representative experiment is shown.
CD40 + IL-4
LPS + IL-4
M17-/-M17+/+
CFSE
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Despite the reduced cell numbers in the Peyers patches, the architecture of
GCs remained unchanged in these tissues (Figure 19B). M17-/- mice are still able
to form GCs with an intact network of FDCs (not shown) and resemble GCs from
wild-type mice. Hence, M17 is not an essential component required for GC
formation.
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Figure 19. GC architecture in M17-/- mice. (A) Mice were immunized with 50 mg NP-CG.
Spleens were analyzed for GC formation 14 days later. Frozen splenic were stained by
immunofluorescence. Sections were incubated with either aCD19 mAb  (green) and PNA
(red) to visualize B cell follicles and GCs or PNA (red) and aFDCM1 mAb (green) to
visualize the network of FDCs within the GCs. SP, spleen; column 1, 10x magnification;
column 2 and 3, 20x magnification. (B) Frozen sections of the Peyer’s patcheswere
stained with aCD19 mAb (green) and PNA (red) to visualize B cells and GCs. Sections
were derived from 2 independent experiments with 2 mice per genotype. Representative
pictures are shown.
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C2.6 Normal Ig Serum Titers and Efficient Class Switching in M17-Deficient
Mice
To analyze the ability of M17-/- mice to undergo CSR, I first measured Ig
antibody titers in the blood serum of unimmunized mice by ELISA. As shown in
Figure 20, M17-/- mice are able to secrete antibodies of all isotypes and reach
antibody levels in their blood serum comparable to wild-type controls. Thus,
deficiency of M17 does not appear to have a major impact on CSR.
While M17-/- mice produce normal amounts of antibodies, M17 may
modulate CSR in more subtle ways.  Hence, I determined the ability of M17-/- B
cells to undergo CSR to particular isotypes in vitro. Splenic B cells from M17-/-
mice and wild-type controls were isolated by MACS depletion of CD43+ cells and
induced with various stimuli to undergo CSR in vitro. After 4 days of culture, the
percentage of class-switched cells was measured by flow cytometry. As expected,
LPS is able to induce efficient CSR to IgG2b and IgG3 in M17-deficient mice as
this stimulus does not induce the expression of M17 mRNA (Figure 21A).
Activation of M17-/- B cells with LPS plus TGF-b or LPS plus IFN-b induces CSR to
IgA and IgG2a at wild-type levels. Activation of M17-/- B cells with aCD40 mAb plus
IL-4 induces the expression of M17 mRNA. However, M17-/- B cells efficiently
switch to IgG1 and IgE isotypes when stimulated with aCD40 mAb plus IL-4.
Finally, I analyzed whether GC B cells in the Peyer’s patches also undergo
efficient CSR (Figure 21B). Most GC B cells in the gut switch to IgA, which is
secreted into the intestinal lumen. Around 40% of GC B cells were IgA+ in M17-
deficient mice, which compared to around 35% in wild-type mice. Therefore, M17
is not required for the induction of CSR or its mechanism in general and switching
to specific isotypes in particular.
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Figure 20. Antibody titers in serum M17-deficient mice. Antibody titers in the serum of
unimmunized wild-type and M17-deficient mice were determined in an ELISA assay. Each
circle represents one mouse. Black bars indicate the geometric means. Closed circles,
wild-type mice; open circles, M17-deficient mice.
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Figure 21. Class-switch recombination in M17-/- mice. (A) In vitro stimulation of isolated
B cells of M17-/- mice and wild-type controls. B cells were induced to undergo CSR with
the indicated stimuli. The percentage of class-switched cells was determined 4 days later
by flow cytometry. Numbers in the graphs represent the percentages of switched cells.
The experiment was performed 3 times and a representative experiment is shown. (B).
Percentage of IgA+ GC B cells in the Peyer’s patches of M17+/+ (left) or M17-/- mice (right).
A representative experiment is shown.
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C2.7 GC B Cells of M17-Deficient Mice Mutate Their Ig Genes Efficiently
  To elucidate whether M17 is involved in SHM of Ig genes, I studied the
intrinsic features of the hypermutation process by analyzing the accumulation of
mutations in the intron downstream of the rearranged V gene in the IgH locus
(Jolly et al., 1997). I immunized pairs of wild-type and M17-deficient mice with 100
mg NP-CG and isolated GC B cells and naïve B cells 14 days post immunization
from spleen to measure the level and pattern of somatic mutations. All mice used
for this analysis responded to NP-CG as demonstrated by the presence of
elevated levels of NP-CG-specific IgG1 antibodies in the blood (data not shown).
The PCR reaction was performed on genomic DNA from 20,000 cell equivalents
using a primer pair that anneals in the framework region 3 of most VHJ558 genes
and in the intron downstream of the JH4 gene, thus comprising a large proportion
of rearranged V genes. PCR products were subcloned, sequenced, and
subsequently controlled for the absence of clonally related sequences.
Sequences derived from naïve B cells were predominantly unmutated
(Table 7). In contrast, the majority of sequences derived from GC B cells of either
wild-type or M17-deficient mice contained somatic mutations. Sequences
harboring one or more mutations were used to analyze the mutational patterns.
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Both wild-type and M17-deficient mice were able to mutate their Ig genes with an
equivalent average mutation frequency (0.75% versus 0.83%, see Table 7) and
the number of mutations per sequence was in similar range (1-12 versus 1-14
mutations per sequence in M17-/- and M17+/+, respectively). The analysis of the
mutational patterns did not reveal major differences between M17-/- mice and wild-
type controls. Adenine remained a highly mutated base in M17-/- mice and there
was no difference in the number of deletions or insertions (Figure 22). Moreover,
the ratio of transitions versus transversions did not change significantly. 
Cell numbers of Peyer’s patches are reduced in M17-deficient mice. I
therefore asked whether SHM could be affected in this cellular compartment.
CD19+Fas+PNA+GC B cells from the Peyer’s patches of 2 unimmunized M17-/-
mice or wild-type mice were isolated by FACS-purification and analyzed for SHM
similarly to the analysis of splenic GC B cells. While the mutation frequency was
higher in GC B cells derived from Peyer’s patches than in splenic GC B cells, I did
not observe an altered mutation frequency in M17-deficient mice when compared
Figure 22. SHM patterns in M17-/- mice. Patterns of nucleotide exchanges in a 500 bp-
long region in the intron downstream of the rearranged VHDHJH4 joints of GC B cells
derived from pairs of M17+/+ and M17-/- mice, respectively. GC B cells were isolated 14
days post immunization with NP-CG. Following cell lysis, a 600 bp fragment was PCR-
amplified from 40.000 cell equivalents using a primer pair that anneals in the framework 3
region of most J558 V genes and in the intron downstream of JH4 gene segment. All
values are shown in %. n, the number of mutations; Ts., transitions; Tv., transversions;
Ts./Tv., the transions over transversions ratio. 
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to wild-type controls (1.70% for M17-/- mice versus 1.62% for M17+/+ mice). The
range of the number of mutations per sequence remained the same and there was
no major difference in the mutational pattern (data not shown). Likewise, the ratio
of transitions to transversions did not change. Hence, M17 is not required for the
efficient introduction of somatic mutations in the Ig genes.
C2.8 Immune Response of M17-Deficient Mice to NP-CG
Finally, I sought to test the primary and secondary antibody response of
M17-deficient mice against the T cell-dependent antigen NP-CG. To this end, I
immunized groups of 7 wild-type or M17-deficient mice with either 50 mg or 10mg
NP-CG in alum per mouse and measured the serum titers of NP-specific IgG1 and
Igl antibodies every 7 days for 4 weeks. The M17-deficient cohort immunized with
50 mg NP-CG yielded a robust and consistent antibody response with a geometric
mean of 117 mg/ml of NP-specific IgG1 at the peak of the immune response (Figure
23A). The response was comparable to wild-type controls. M17-deficient mice
immunized with 10 mg NP-CG in alum gave rise to a similar immune response
against NP-CG, albeit at lower levels. The immune response peaked at 56 mg/ml
of NP-specific IgG1 14 days post immunization and was indistinguishable from the
response in wild-type mice (Figure 23B). The measurement of the NP-specific Igl
antibodies gave similar results (not shown).
Next, I evaluated the ability of M17-/- mice to mount an efficient secondary
immune response against NP-CG. The same mice used for the analysis of the
primary immune response were immunized with 10 µg NP-CG without alum 63
days after the primary immunization. The secondary immune response was
followed for three weeks. M17-/- mice that had been immunized with 50 µg NP-CG
for the primary immune response were also able to mount a secondary response.
However, the secondary response was moderately weaker in M17-/- mice than in
the wild-type controls (Figure 23C). While M17+/+ reached a geometric mean of 804
µg/ml at the peak of the secondary immune response, M17-/- mice peaked at
247µg/ml (Figure 23C). Mice that had been immunized with 10 µg/ml in the
primary immune response gave a similar result (Figure 23D). Thus, M17-/- mice
have a secondary immune response.
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Figure 23. Primary (A, B) and secondary (C, D) immune response of M17-/- mice and
wild-type controls to NP-CG. (A) Primary immunization with 50 µg NP-CG in alum. (B)
Primary immunization with 10 µg NP-CG in alum. (C) Secondary immunization with 10 µg
NP-CG without alum of mice previously immunized with 50 µg NP-CG. (D) Secondary
immunization with 10 µg NP-CG without alum of mice previously immunized with 10 µg.
Each circle represents one mouse. Bars indicate the geometric means. Closed circle,
M17+/+ mice; open circle, M17-/- mice.
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D. DISCUSSION
D1. The Role of Polk and Other DNA Polymerases in SHM
Error-prone DNA polymerases are required for the bypass of DNA lesions
at stalled replication forks. They can bypass their cognate lesions accurately and
are mutagenic when copying non-cognate lesions or undamaged templates.
Several reported deficiencies of mammalian DNA polymerases were either
embryonic lethal (Polb, Polz)(Bemark et al., 2000; Esposito et al., 2000a; Gu et al.,
1994a; Wittschieben et al., 2000) or resulted in a increased susceptibility to skin
cancer (Polh)(Masutani et al., 1999). In contrast, my studies show that Polk-
deficient mice are viable and do not exhibit obvious abnormalities.
The observation of increased sensitivity to killing of Polk-deficient MEFs
following exposure to UV radiation supports the notion that like other specialized
DNA polymerases with abnormally low fidelity, Polk is required for the replicative
bypass of one or more types of base damage produced by UV radiation. The
independent observation that Polk is able to bypass the minor photoproduct
thymine glycol, but not the major photolesions thymine dimers and [6-4]
photoproducts in vitro (Fischhaber et al., 2002), confirms the idea that Polk is
required for translesion synthesis across certain types of base damage in vivo.
Polk has also been found to serve as an efficient extender from mismatched
primer termini generated by other DNA polymerases (Haracska et al., 2002;
Washington et al., 2002). In this latter role, Polk has been implicated in the bypass
of thymine dimers (Washington et al., 2002), thus explaining the increased UV
sensitivity of Polk-deficient fibroblasts. Another function of Polk may be the bypass
of aromatic DNA adducts. Expression of Polk is augmented by aromatic
compounds (Ogi et al., 2001) and polyaromatic hydrocarbons such as
benzopyrenes serve as good substrates for Polk (Huang et al., 2003; Suzuki et al.,
2002; Zhang et al., 2002). Consequently, increased expression of Polk has been
found in the adrenal cortex, where steroid synthesis occurs, (Velasco-Miguel et al.,
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2003) and in specimens of several lung cancers (J et al., 2001).
Thymine glycols represents DNA lesions that often result from the presence
of reactive oxygen species (Hegi et al., 1989). Reactive oxygen species have been
associated with DNA damage of spermatozoa (Gil-Guzman et al., 2001; Ollero et
al., 2001). Polk copies faithfully across thymine glycols (Fischhaber et al., 2002).
The high levels of expression of Polk  mRNA in testis in both meiotic and post-
meiotic cells (Velasco-Miguel et al., 2003) were suggestive of a possible
specialized role(s) for this enzyme during spermatogenesis. However, the
architecture of the testis in the Polk mutant mice appears to be normal and the
mice are fertile over several generations. Many error-prone DNA polymerases are
strongly expressed in testis (Aoufouchi et al., 2000; Garcia-Diaz et al., 2000;
McDonald et al., 1999). Base-excision repair is involved in the repair of
spontaneous DNA damage such as thymine glycols and other lesions and is a
very efficient DNA repair pathway in germ cells (Olsen et al., 2001).  Poll and Poli,
which are also highly expressed in the seminiferous tubules of the mouse testis,
have been implicated to operate in base excision repair (Bebenek et al., 2001;
Garcia-Diaz et al., 2000; McDonald et al., 1999). It was therefore conceivable that
Polk, Poll, and Poli together contribute to the genome integrity in testis. However,
compound mutants that are deficient of Polk, Poll, and Poli are viable, reproduce
normally and do not show any visible abnormalities, arguing against cumulative
functions of these DNA polymerases during spermatogenesis (unpublished own
data). At the present time, I cannot rule out that the absence of Polk or other DNA
polymerases results in the accumulation of mutations in the germline, which might
affect fertility or viability of the mice in later generations. In this context, it is
interesting to note that one colony of Polk-/- mice developed diabetes insipidus and
the onset of the disease decreased over several generations (Errol Friedberg,
Southwestern Medical Center, Dallas, USA, personal communication). The reason
for this phenotype is not know. However, one can speculate that normally Polk
copies faithfully across base damages that arise during spermatogenesis, such as
thymine glycols, and the absence of Polk leads to mutations, which in this case
affected a gene responsible for the this particular phenotype.
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Somatic hypermutation introduces mainly point mutations but deletion and
insertion also occur (Goossens et al., 1998; Kocks and Rajewsky, 1988; McKean
et al., 1984). The discovery of AID has furthered the understanding of the initiation
of SHM. Deamination of cytidines by AID leads to the formation of uracil residues.
Subsequent DNA replication across this lesion results in the incorporation of
adenine opposite uracil and thus to the introduction of C to T transitions (Petersen-
Mahrt et al., 2002). UNG-deficient mice fail to efficiently remove uracil residues
due to their impaired uracil-deglycosylase function and consequently harbor
elevated levels of transition mutations in their Ig genes (Rada et al., 2002).
However, although somatic mutations tend to cluster in the context of the RGYW
hotspot motifs, they are scattered throughout the Ig genes and occur at all four
bases. Importantly, they represent not only transitions but also almost 50%
transversions. Which factors can account for this pattern? A role of error-prone
DNA polymerases in SHM has long been considered (Bertocci et al., 1998;
Brenner and Milstein, 1966; Diaz et al., 1999) and the class of recently discovered
error-prone DNA polymerases has attracted considerable attention in this regard.
Uracil-deglycosylation creates abasic sites, which are either non-instructive sites
during DNA replication or the origin of DNA strand breaks, whose repair involves
error-prone short-patch DNA synthesis (Di Noia and Neuberger, 2002; Petersen-
Mahrt et al., 2002). Alternatively, the mismatch-repair enzymes MSH2 and MSH6
recognize the U-G mismatches and subsequent error-prone short-patch DNA
synthesis introduces mutations (Jacobs et al., 1998; Phung et al., 1998). Error-
prone DNA polymerases exhibit varying degrees of processivity or fidelity and
different abilities to synthesize from mismatched or misaligned DNA termini. For
example, Poli is very mutagenic when copying undamaged template but has poor
processivity, whereas Polz extents mismatched termini efficiently. It is therefore
conceivable that the resulting mutation pattern of SHM is due to the combined
action of AID and several error-prone DNA polymerases.
The mutagenic nature of Polk and its expression in B cells were suggestive
of a role of this enzyme in SHM mechanism of Ig genes. Here I show that Polk-
deficiency does not affect B cell development and the formation of GC B cells. The
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mutant mice are still able to produce normal antibody serum titers and to mount a
robust T cell-dependent immune response. To test the ability of Polk-/- mice to
introduce somatic mutations in their Ig genes, I examined the mutation frequency
and pattern in the non-biased intron downstream of rearranged V genes containing
the JH4 gene segment. The mutation frequency in sequences derived from Polk
-/-
mice (1.0 and 1.1 %) is similar to the ones in sequences derived from wild-type
controls (0.9 and 1.3%). Likewise, the mutation pattern of SHM stayed essentially
the same between the two groups of mice, even when excluding Gs in the second
position of RGYW hotspots. Adenine was still the most frequently mutated base
and the ratio of transitions to transversion did not change (1.0 and 1.2 versus 1.0
and 1.1). Polk can introduce frameshift mutations in vitro. However, my analysis
does not reveal differences with respect to the number of frameshift or tandem
mutations. The present work therefore demonstrates that Polk is not an essential
component of the hypermutation machinery. This finding was recently also
confirmed in a Polk-deficient mouse strain that was generated independently from
the one analyzed here (Shimizu, 2003).
Several other error-prone DNA polymerases are also dispensable for SHM
in vivo.  Mice deficient of Polb, Pold, Poll, Poli, or Polm mutate their Ig genes
efficiently and these polymerases do not show a significant change in their
mutational pattern (Bertocci et al., 2002; Esposito et al., 2000a; Longacre et al.,
2003; McDonald et al., 2003). Nonetheless, evidence for the involvement of error-
prone DNA polymerases in the SHM mechanism has been accumulated in recent
years. For example, the error-spectrum of Polh in vitro correlates with mutations at
SHM hotspots (Pavlov et al., 2002; Rogozin et al., 2001). While the frequency of
SHM in Polh-deficient XP-V patients reaches normal levels, the mutation pattern is
biased towards G-C mutations. Thus, Polh it is probably responsible for many of
the mutations at A-T nucleotides (Zeng et al., 2001). Polz is thought to introduce
mutations when extending from mismatches incorporated by other DNA
polymerases (Diaz et al., 2001; Zan et al., 2001). One of the latter DNA
polymerases may be Poli, which was found to interact with Polz. Deficiency of Poli
in a hypermutating cell line results in the reduction of G-C mutations (Faili et al.,
2002). However, the significance of this finding is unclear, because Poli-deficient
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mice mutate their Ig genes at normal levels without obvious changes in the
mutational patterns (McDonald et al., 2003). This apparent paradox could be
explained by the expression of a particular DNA polymerase in cell lines, but the
synergistic and redundant action of several DNA polymerases during SHM in vivo.
To investigate whether several DNA polymerase have overlapping function
during SHM, I started to generated compound mutant mice deficient of Polk, Poll,
and Poli. Somatic hypermutation in compound mutant mice deficient of these three
DNA polymerases appear to mutate their Ig genes normally. Both the mutation
frequency and the mutation patterns resemble those in wild-type controls. The
ratio of transition versus transversions remains basically the same and the number
of deletions or insertions does not change. In the light of this finding, it seems
unlikely that the combined contribution of of Polk, Poll, and Poli to SHM is
significant. However, their function in SHM can still be substituted by other error-
prone DNA polymerases. One of the candidates for such a function is Polm. The
lymphoid-specific TdT-like Polm acts in a template-dependent but sequence
independent manner and has been implicated in the processing of DNA ends
during Ig light chain rearrgangement (Bertocci et al., 2003). However, its
expression is not restricted to developing lymphocytes. Polm is also found in GC B
cells and this expression pattern was suggestive of specialized function during
SHM. Yet, it is not an essential component for the SHM process as mice deficient
of Polm mutate their Ig genes normally (Bertocci et al., 2002). l am currently in the
process of intercrossing Polk-/-Poll-/-Poli-/- with mice deficient of Polm to explore
the question of the redundant function of DNA polymerases in SHM further.
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D2 Function of M17 in the Immune System
Diffuse large B cell lymphomas (DLBCL) are a heterogeneous group of
tumors with diverse clinical features and distinct gene expression profiles (Lossos
and Levy, 2003). Patients with DLBCL can be subgrouped according to the
expression of HGAL in these tumors. HGAL can serve as a prognostic marker for
the clinical outcome in patients with DLBCL (Lossos et al., 2003). High expression
of HGAL in DLBCL results in a better clinical prognosis with longer survival rates.
However, the biological function of HGAL is unknown. In this study, I have
investigated mice deficient of M17, the murine homologue of HGAL, to elucidate its
role in B cell function.
The M17 and HGAL genes share a similar exon-intron structure and the
respective proteins are homologous to each other but not to other known proteins.
Both proteins contain several potential phosphorylation sites and include a non-
canonical ITAM motif. These features suggest that HGAL and M17 are true
homologues (Lossos et al., 2003; Pan et al., 2003). However, M17 and HGAL
differ substantially at the N-terminus as HGAL possesses an elongated N-terminus
due to exon 2 in the HGAL mRNA, which is absent from the published M17 mRNA.
During the course of this analysis, I detected a novel isoform of the M17 mRNA
that contains a previously unidentified exon. The novel exon is located between
exon 1 and 2 of the M17 mRNA and of similar length as exon 2 of the HGAL
mRNA. It can thus account for the discrepancy in the length of the N-terminus
between HGAL and M17.
M17 and HGAL share overlapping but not identical expression patterns.
M17 is expressed at low levels in developing B cells and is predominantly
expressed in GC B cells (Christoph, 1993; Christoph et al., 1994). This very
specific expression pattern was suggestive for a function of M17 within the GC
reaction. Here, M17 may play a role in cell signaling due to the presence of a non-
canonical ITAM motif. The expression of HGAL mRNA is upregulated in naïve B
cell upon stimulation with the cytokine IL-4. My observation that the expression of
M17 mRNA can also be induced by IL-4 in LPS or CD40-activated B cells
suggests that expression of HGAL and M17 are regulated by a similar mechanism.
IL-4-mediated signaling plays an important role in GC function and is particularly
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essential for CSR from Cm to the Cg1 and Ce isotypes (Kühn et al., 1991) . Thus,
the IL-4-induced expression of M17 is consistent with the notion that M17 plays a
role within the GCs, where it may function during certain aspects of IL-4 mediated
events.
M17 is expressed in developing B cells (Christoph, 1993). In this study, I
show that both the pro-B and pre-B cell fractions are present at wild-type levels in
M17-/- mice. B cell development appears to be unaffected in the absence of M17.
M17 therefore seems to be dispensable for B cell development. However, the
precise role of M17 in this cellular compartment requires further investigation. M17
was originally isolated via a cDNA subtraction between GC B cells and LPS-
stimulated B cells. Thus, it was not surprising that naïve B cells do not require
M17. Splenocytes are present at normal numbers in M17-/- mice and the
proportions of the major B and T cell subsets are not altered.
Immunization of M17-/- mice with a T cell-dependent (TD) antigen leads to
the formation of GC B cells and the size of this specialized compartment is similar
to wild-type controls. GC B cells in M17-/- are morphologically organized like wild-
type GCs. GCs of M17-/- mice are separated into the dark zone and the FDC-rich
light zone and are equal to wild-type GCs with respect to number and size. Thus,
M17 is not required for GC formation. M17-deficent B cells proliferate equally well
as wild-type controls when stimulated with anti-IgM or anti-CD40 mAbs in the
presence of IL-4. It appears unlikely that GC B cell proliferation is affected by the
lack of M17. IL-4 is a critical cytokine for CSR to IgG1 and IgE (Kühn et al., 1991).
The upregulation of M17 mRNA after stimulation with an aCD40 mAb and IL-4
suggested the involvement of M17 in CSR to IgG1 and IgE. However, the
presence of wild-type levels of antibody serum titers in M17-deficient mice and the
in vitro ability of B cells from these mice to undergo CSR to all isotypes including
the aCD40 and IL-4-induced isotypes IgG1 and IgE show that M17 is not essential
for CSR. In addition, M17-/- mice undergo efficient SHM in response to a TD
antigen. The mutation frequency and patterns are comparable to wild-type mice.
Primary TD immune responses reach NP-specific IgG1 levels in the serum similar
to those found in wild-type mice and this characteristic is independent of the
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amount of immunizing antigen. Thus, M17 is surprisingly dispensable for the core
events of the GC reaction during a primary immune response.
Besides the high expression of HGAL in GC B cells, expression of HGAL
mRNA is also found at low levels in memory B cells (Lossos et al., 2003). In vitro
studies indicated a role for IL-4 in the promotion of memory B cell formation (Choe
et al., 1997) and the alteration of homing properties of B cell during this process
(Roy et al., 2002). For this reason, HGAL has been suggested to participate in the
differentiation of memory B cells. Some M17+ cells localize to the marginal zone
(Christoph, 1993), where memory B cells reside in the spleen. However, M17-/-
mice produce normal NP-specific IgG1 serum titers upon secondary antigen
challenge. Although the current data do not lend strong support to the hypothesis
of an involvement of M17 in memory B cell formation, it is still possible that M17 is
involved in such a process. Further studies involving bone-marrow chimeras of
M17-/- and wild-type cells will help to investigate this question.
The analysis of Peyer’s patches M17-/- mice revealed that the absence of
M17 affects the Peyer’s patches. M17-defcient mice have a reduced number of
Peyer’s patches per mouse and the individual Peyer’s patches are often smaller in
size. These two effects combined result in a 2-3 fold reduction of total cells in the
Peyer’s patches. The ratio of T versus B cells, however, remains normal in Peyer’s
patches when compared to wild-type mice. In particular, the size of GC B cells
populations is not altered in the Peyer’s patches of M17-/- mice and the
architecture of the GCs is undisturbed. On a functional level, GC B cells in the
Peyer’s patches of M17- / -  mice are capable of class switching to IgA, the
predominant isotype in the gut. Likewise, the reduced number of cells in the
Peyer’s patches does not affect SHM as both the mutation frequency and mutation
patterns are equal to wild-type controls.
It is surprising that the absence of M17 affects the cell number of the
Peyer’s patches. The lymphotoxin (LT)-driven development of Peyer’s patches
occurs in three stages (Adachi et al., 1997). It commences in the embryo at day 15
post gestation with the formation of clusters of cells expressing the adhesion
molecules VCAM and ICAM and is followed by the entry of hemapoetic cells a few
days later. Entry of mature lymphocytes completes the development of mature
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Peyer’s patches just prior to birth but is not required for the compartmentalization
of Peyer’s patches (Hashi et al., 2001). The expression pattern of M17 during
embryogenesis has not been investigated. Since the cellularity of the Peyer’s
patches does not change in M17-deficient mice, it seems possible that the
reduction in cell numbers is not due to a B cell-specific effect. Alternatively, M17
may modulate homing properties of B cells, which become apparent during the
formation and development of Peyer’s patches. In this context, it is interesting to
note that IL-4 can augment autocrine lymphotoxin production in B cells (Worm et
al., 1998). Mice with B cell-specific ablation of LTb show a disturbed splenic
microarchitecture and a reduced size of Peyer’s patches with intact B and T cell
compartments (Tumanov et al., 2002). The former phenotype is not seen in M17-/-
mice. However, in the light of the latter finding, one can speculate that M17-
mediated signals might modulate the formation of Peyer’s patches.
At the present time, it is unclear whether high expression of HGAL in
DLBCL merely identifies a particular subset of lymphomas with a beneficial
prognosis or is indeed a reflection of the biological function of HGAL. High
expression of BCL6, which is expressed in GCs and serves as another prognostic
marker for patients with DLBCL, is also indicative of better overall survival (Lossos
et al., 2001). Moreover, elevated co-expression of both genes appears to have
cumulative effects with respect to survival (Lossos et al., 2003). Interestingly,
expression of both genes can be induced by IL-4. Expression of HGAL and BCL6
therefore identifies GC-derived tumors that are exposed to higher IL-4 levels. IL-4
can inhibit in vitro proliferation in lymphoma cells (Defrance et al., 1992; Taylor et
al., 1990). Such growth-moderating effects could be mediated by HGAL and M17
and would predict stronger proliferation of M17-/- B cells and possibly enlarged
GCs. These effects have not been observed in M17-/- mice and hence argue
against such a hypothesis. On the other hand, high expression of HGAL and BCL6
may simply identify tumors that originate from B cells at a particular differentiation
stage. DLBCL can be separated into distinct subtypes. The more malignant type is
derived from activated B cells, while the more benign subtype is of GC B cell origin
(Alizadeh et al., 2000). HGAL marks subsets of DLBCL with a better prognosis and
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may even identify DLBCL derived from particular GC subsets, for example
centroblasts or centrocytes. Given the moderate phenotype of M17-/- mice in GC
formation and function, I would favor the latter explanation.
In conclusion, M17 does not affect B or T cell development in a major way.
M17 is dispensable for GC formation, B cell proliferation, Ig class switching, SHM
and the formation of an immune response against a TD antigen. The biology of
M17 suggests that HGAL serves as a prognostic marker for the improved survival
of DLBCL patients in a more indirect way. However, M17-/- mice have less and
smaller Peyer’s patches, indicating a potential role in the organogenesis of Peyer’s
patches.
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E SUMMARY
In T cell-dependent immune responses, activated B cells undergo a phase
of rapid expansion and form distinct histological structures, the germinal centers
(GC). GCs are the sites of secondary antibody diversification. Somatic
hypermutation (SHM) introduces mutations into the rearranged V genes, whereas
class switch recombination (CSR) alters the IgH constant region to modulate
effector function.
The current model of SHM postulates cytidine deamination by AID, followed
by error-prone repair that involves short-patch DNA synthesis by error-prone DNA
polymerases. The Polk (DinB1) gene encodes a specialized mammalian DNA
polymerase called DNA polymerase k. The mouse Polk gene is expressed in most
tissues of the body including B cells. The ability of Polk to generate mutations
when extending primers on undamaged DNA templates identifies this enzyme as a
candidate for the introduction of nucleotide exchanges during SHM. Here, I show
that Polk-deficient mice are viable, fertile and able to mount a normal immune
response to the antigen (4-hydroxy-3-nitrophenyl) acetyl-chicken globulin (NP-
GC). Polk-deficient mice mutate their Ig genes normally. Polk-/-Poll-/-Poli-/- mice
also show no defects in SHM, indicating that these error-prone DNA polymerases
do not substitute for each other’s function during SHM. However, Polk-deficient
embryonic fibroblasts are sensitive to cell death following exposure to ultraviolet
radiation, suggesting a role for Polk in translesion DNA synthesis.
The human gene HGAL serves as marker in the prognosis of patients with
GC-derived diffuse large B cell lymphomas (DLBCL). The mouse gene M17 is the
homologue of HGAL. M17 is predominantly expressed in the GCs, indicating a role
in GC function. In the present study, I analyzed M17-/- mice to investigate the role
of M17 in the GC reaction. M17-/- mice form normal GCs, undergo efficient CSR
and SHM and mount a T cell-dependent immune response. Thus, M17 is
dispensable for the GC reaction and the current data support a rather indirect role
for HGAL as a prognostic marker in the biology of DLBCL.
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F ZUSAMMENFASSUNG
Aktivierte B Zellen proliferieren während T Zell-abhängigen
Immunantworten und bilden definierte histologische Strukturen, die Keimzentren.
Dort findet die sekundäre Diversifikation der Antikörper statt: Somatische
Hypermutation (SHM) fügt Mutationen in den zusammengefügten V Genen ein
und Klassenwechsel-Rekombination ändert die konstante Region der schweren
Immunglobulinkette.
Das aktuelle Model der SHM postuliert zunächst eine Cytidin-Deaminierung
durch AID und anschliessende fehlerhafte DNA Reperatur, die zum Teil durch
fehlerbehaftete DNA Polymerasen verursacht wird. Die fehlerbehaftete DNA
Polymerase k (Polk) wird in den meisten Geweben exprimiert, darunter auch in B
Zellen. Die Fähigkeit von Polk, Mutationen während der DNA Synthese einfügen
zu können, legt eine Beteiligung dieser DNA Polymerase an der SHM nahe. In
dieser Arbeit habe ich daher Polk-/- Mäuse generiert, um diese Frage zu klären.
Polk-/- Mäuse sind lebensfähig und zeugungsfähig. Die mutanten Mäuse haben
eine normale T Zell-abhängige Immunantwort und mutieren ihre Immunglobulin
Gene in gleichen Massen wie Polk+ / +  Mäuse. Analyse von Polk-/-Poll-/-Poli-/-
Mäusen ergibt ein vergleichbares Ergebnis, was eine austauschbare Funktion der
drei DNA Polymerasen in SHM unwahrscheinlich erscheinen lässt. Hingegen ist
Polk wichtig für die DNA Reperatur, da Fibroblasten aus Polk+/+  Mausembryos
eine erhöhte Sterblichkeit nach Bestrahlung mit ultraviolettem Licht zeigen.
Das humane Gen HGAL dient als Marker für die klinische Prognose von
Tumoren des Keimzentrums. Das Maushomolog von HGAL heisst M17 und ist
vorwiegend in den Keimzentren exprimiert. Ich habe M17-/- Mäuse analysiert, um
die Rolle von M17 in der Keimzentrums-Reaktion zu verstehen. M17-/- Mäuse
bilden normale Keimzentren, führen effiziente SHM und Klassenwechsel-
Rekombination durch, und reagieren in der Immunantwort ähnlich wie wild-typ
Kontrollen. Der gegenwärtige Kenntnisstand unterstützt eher eine indirekte Rolle
für H G A L  als Marker in der Biologie von Tumoren des Keimzentrums.
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H ABBREVIATIONS
AID activation-induced deaminase
APC Allophycocyanine
BCR B cell receptor
bp base-pairs
BSA bovine serum albumin
C constant region
CSR class switch recombination
D diversity gene segment
DLBCL diffuse large B cell lymphoma
DMEM Dulbecco’s modified Eagle medium
DMSO Dimethylsuloxide
EDTA ethylene-diamine tetraacidic acid
EGFP enhanced green fluorescence protein
ES cell embryonic stem cell
FACS fluorescence assisted cell sorting
FCS fetal calf serum
FDC follicular dendritic cell
FITC Fluoresceine-isocyanate
GC germinal center
Ig immunoglobulin
IgH immunoglobulin of the heavy chain locus
IgL immunoglobulin of the light chain loci
IL-4 Interleukin-4
i.p. intra-peritoneally
J joining gene segment
kDa kilo Dalton
LA long arm of homology
LIF leukemia inhibitory factor
LPS lipopolysaccaride
mAb monoclonal antibody
MACS magnetic cell sorting
Abbreviations 111
MEF mouse embryonic feeder cells
MLN mesenteric lymph node
NHEJ non-homologous end joining
PBS phosphate-buffered saline
PCR polymerase chain reaction
PE Pycoerythrine
Pol DNA polymerase
PNA peanut agglutinin
PP Peyer’s patches
R purine (adenine or guanine)
RPMI Rosewell-Park-Memorial-Institute cell culture medium
RSS recognition signal sequence
SA short arm of homology
SDS sodium dodecyl sulfate
SP spleen
SHM somatic hypermutation
TD T cell-dependent
Tris tris(hydroxymethyl)amineethane
W adenine or thymidine
WT wild-type
V variable gene segment or variable region
Y pyrimidine (cytidine or thymidine)
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